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ABSTRACT 
 
Since antiquity, man has always believed in the healing properties of plants. The age-old 
practice of phytotherapy is now justified by numerous phytochemical and pharmacological 
studies which substantiate the presence of biologically active compound(s) in some medicinal 
plants. Quite often, ethnopharmacological studies provide important leads for the development 
of different types of plant-based therapeutic drugs. New effective antibiotics are urgently 
needed to combat multiple and extensively drug-resistant bacterial strains that are currently 
threatening public health globally. The rich floral diversity in southern Africa and the resultant 
extensive chemical diversity provide encouraging prospects for discovering novel 
pharmacologically important phytocompounds within this region. Against this background, the 
current study was designed to evaluate the in vitro antibacterial properties, phenolic profiles 
and mutagenic potentials of extracts obtained from seven South African plants used 
traditionally to manage bacterial infections and where the active principles were unknown. The 
study also aimed at identifying the principal antibacterial compound(s) in selected plants that 
demonstrated potent and broad-spectrum antibacterial properties. 
 
Aqueous and organic solvent extracts of the seven selected plants namely Bolusanthus 
speciosus, Cucumis myriocarpus, Ekebergia capensis, Protea caffra, Prunus africana, Searsia 
lancea and Solanum panduriforme were screened for antibacterial (minimum inhibitory 
concentration, MIC) properties against a panel of seven bacterial strains (Enterococcus 
faecalis, Escherichia coli, Klebsiella pneumoniae, multiple drug-resistant (MDR) E. coli, 
MDR K. pneumoniae, drug-sensitive Staphylococcus aureus and penicillin-resistant S. aureus) 
using the microdilution technique. The extracts were also screened for antigonococcal 
properties using microdilution and agar disk-diffusion techniques. In addition, combinations of 
 
 
ix 
 
the different plant extracts, as well as plant extracts with four antibiotics (ampicillin, 
cefotaxime, chloramphenicol and penicillin) were evaluated for antibacterial synergistic 
interactions against MDR Gram-negative bacterial strains (E. coli and 
K. pneumoniae) using the checkerboard titration and time-kill bio-assays. Preliminary 
phytochemical analyses for phenolics in aqueous methanol (50% MeOH) plant extracts were 
conducted using spectrophotometric methods. In addition, specific phenolic acids in 80% 
MeOH extracts of the plants were quantified with the use of ultra-high-performance liquid 
chromatography-tandem mass spectrometry (UHPLC-MS/MS). The mutagenic properties of 
plant extracts that demonstrated noteworthy antibacterial activities (MIC<1 mg/ml) were 
assessed using the Ames Salmonella/Microsome assay involving two tester strains, TA98 and 
TA102 (without S9 metabolic activation).  
 
The most potent antibacterial activities were exhibited by the MeOH bark extracts of 
B. speciosus which yielded MIC values of 0.039 and 0.078 mg/ml against S. aureus (penicillin-
resistant and drug-sensitive strains, respectively). Dichloromethane (DCM) leaf extracts of  
S. lancea yielded an MIC value of 0.63 mg/ml against five of the seven test bacterial strains 
including MDR E. coli and MDR K. pneumoniae. B. speciosus bark (MeOH and DCM),  
P. caffra seeds (DCM) and twigs (MeOH) also demonstrated broad-spectrum antibacterial 
activities. B. speciosus MeOH bark extracts, as well as the DCM leaf extracts of P. africana 
and S. lancea demonstrated moderate antigonococcal properties (MIC range: 0.31-0.63 
mg/ml). The checkerboard assay detected antibacterial synergistic interactions in combinations 
of chloramphenicol with each of B. specious leaf MeOH extracts, P. africana leaf MeOH and 
DCM extracts against MDR E. coli (fractional inhibitory concentration index ≤ 0.5). However, 
the time-kill assay did not detect any significant synergistic interactions in any of these three 
aforementioned combinations. Total phenolic content in the plant extracts investigated ranged 
 
 
x 
 
from 2.38 to 62.73 mg gallic acid equivalents (GAE)/g dry matter. Variations in the quantities 
of flavonoids, condensed tannins, hydroxybenzoic and hydroxycinnamic acids among these 
plant extracts were also observed. In generally, higher levels of phenolic compounds were 
detected in S. lancea (leaves), P. africana (leaves) and P. caffra (leaves, twigs), while lower 
levels were detected in B. speciosus (barks), C. myriocarpus (fruits) and S. panduriforme 
(fruits, leaves, roots, stem). Based on the Ames test, all test plant extracts were non-mutagenic 
against Salmonella typhimurium tester strain TA98 and TA102 (without S9 metabolic 
activation).  
 
S. lancea leaves and P. caffra twigs demonstrated broad-spectrum antibacterial properties and 
as a result, a detailed analysis of their phytochemical constituencies was conducted. 
Antibacterial activity directed fractionation led to the isolation of two compounds from the 
aqueous (80%) MeOH leaf extracts of S. lancea. The isolated compounds were characterised 
using NMR data and both of them demonstrated noteworthy antibacterial activities  
(MIC range: 0.016-0.25 mg/ml) against E. faecalis and S. aureus. 1-Tetracosanol (43.98%), 
1-nonadecanol (37.5%), eicosane (7.67%), 1,7-di-iso-propylnaphthalene (4.23%), 
1-pentadecanol (3.04%), 2,6-di-iso-propylnaphthalene (1.96%) 1,3-iso-propylnaphthalene 
(1.62 %) were identified by GC-MS in an active S. lancea leaf ethyl acetate sub-fraction. The 
sub-fraction inhibited the growth of both E. faecalis and S. aureus at an MIC value of  
0.25 mg/ml. 1-Tetracosanol and 1-nonadecanol, which accounted for more than 80% of the 
total phytochemical constituents of the fraction, are known antibacterial compounds which 
most likely contributed to the antibacterial properties of S. lancea leaves. Gas chromatography-
mass spectrometry (GC-MS) analysis also revealed the presence of 15 compounds in three 
fractions obtained from a methanolic P. caffra twig extract. Two of the identified compounds, 
1-adamantanecarboxylic acid and levoglucosan, are often incorporated into antimicrobial 
 
 
xi 
 
moieties to improve the efficacy of the therapeutic molecule, or as carbon skeletons. Two 
known antibacterial compounds, namely 1-heptacosanol and 1-nonadecanol were also among 
the compounds detected in the methanolic P. caffra twig extract.  
 
Overall, the present study reaffirmed that botanical medicines can potentially be used to 
manage drug-sensitive and drug-resistant bacterial infections often prevalent in humans. The 
study also provided the scientific rationale for the use of P. caffra, C. myriocarpus and  
S. panduriforme in South African folk medicine. 
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CHAPTER 1:Introduction  
 
1.1. South African biodiversity and medical bio-prospecting 
Approximately 80% of the South African population depends on medicinal plants as 
supplements or alternatives to synthetic pharmaceutical drugs (NATTRASS, 2008). These 
phytomedicines are often prescribed by herbalists or ‘witch doctors’ as remedies for both 
spiritual and health care problems (VAN WYK, 2008). Extensive research into botanical 
medicines over the past few decades has resulted in the herbal and natural plant products 
industry becoming a prominent feature of South Africa’s agribusiness (MANDER AND 
MCKENZIE, 2005; MANDER et al., 2007; VAN WYK, 2008). This perhaps explains why in 1998 
the South African government embarked on a ‘Proudly South African’ campaign in a bid to 
promote the trading of its natural products on the international market  
(MAKUNGA et al., 2008). African potato (Hypoxis hemerocallidea), devil’s claw 
(Harpagophytum procumbens) and rooibos (Aspalathus linearis) are some classical examples 
of commercially important South African medicinal plants that have attained international 
status in recent times (VAN WYK, 2015).  
 
South Africa’s rich biodiversity continues to captivate the attention of both international and 
local ethnopharmacologists (VAN STADEN, 2008). VAN WYK (2008) observed that since the 
year 1995, there has been a steady increase in the number of ethnobotanical publications, 
citations and patents on South African medicinal plants. Some of the over 3 000 South African 
medicinal plant species (VAN WYK et al., 1997) including Bolusanthus speciosus, Helichrysum 
aureonitens, Helichrysum caespitium, Veronia colorata and Warburgia salutaris have been 
shown to have potent antibacterial activities (VAN VUUREN, 2008; MULAUDZI et al., 2011). 
Antibacterial synergistic studies also indicate that antibiotic resistance modifying molecules 
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could potentially be obtained from South African medicinal plants including Combretum 
edwardsii, Combretum krausii (CHUKWUJEKWU AND VAN STADEN, 2016), Centratherum 
punctatum (CHUKWUJEKWU et al., 2018), Merwilla plumbea (NCUBE et al., 2012), to mention 
but a few. The extensive floral diversity within this country (GERMISHUIZEN AND MEYER, 
2003) provides a potential rich source of structurally diverse biologically active molecules 
which could be useful in combating both drug-sensitive and -resistant microbial strains. 
 
1.2. Aims and significance of the study 
The current study primarily aimed at identifying the principal antibacterial molecules in some 
South African medicinal plants with potent and broad-spectrum antibacterial properties. South 
Africa has a rich floral diversity which has been under-explored with regards to medical 
bioprospecting. Even though some South African medicinal plants have been shown to have 
potent antibacterial properties, the principal antibacterial compounds within some of these 
plants are unknown. Little is also currently known about the susceptibility of drug-resistance 
bacterial strains to extracts from these plants. Furthermore, the interspecies synergistic 
interactions of South African medicinal plant extracts, as well the interactions of these plant 
extracts with conventional antibiotics remain largely unknown. Findings from this study may 
provide further justification for the traditional use of indigenous plants in South Africa, reveal 
novel sources of potent and extended-spectrum antibacterial compounds, as well as provide 
leads for the discovery and development of new antibacterial compounds with potential use in 
both mono- and/ or combination therapies. 
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CHAPTER 2: Literature review 
 
2.1. Literature review on selected medicinal plants 
Plants are known to produce a myriad of structurally diverse secondary metabolites, some of 
which have significant medicinal properties (GURIB-FAKIM, 2006). By the mid-70’s, 
approximately 75% of all pharmaceutical drugs present were developed as a direct result of 
extensive ethnopharmacological research (FARNSWORTH AND BINGEL, 1977). Artemisinin, 
aspirin, camptothecin, quinine and taxol are some examples of the over 7 000 popular 
therapeutic drugs developed from efficacious plant extracts (TSHIBANGU et al., 2002). 
 
Pharmacological and phytochemical evaluations of South African medicinal plants have led to 
a marked increase in the commercialization of herbal products from this country (MAKUNGA 
et al., 2008; MOTEETEE AND VAN WYK, 2011). Buchu water (STREET AND PRINSLOO, 2012), 
marula creams, marula jams (SHACKLETON et al., 2003) and umkalor  (VAN WYK, 2011) are 
but a few classical examples of pharmaceutical and cosmetic products developed from South 
African medicinal plants. However, given that only a small proportion of South African 
medicinal plants have been tested pharmacologically (PIETERS AND VLIETINCK, 2005), there 
still exist encouraging prospects of discovering several novel bioactive compounds from this 
country’s rich floral diversity. For the current study, Google scholar 
(https://scholar.google.com) was used to search for South African medicinal plants used 
traditionally to manage different bacterial infections and where the active principles had not 
yet been identified. Based on these criteria and material availability, seven traditional medicinal 
plants namely Bolusanthus speciosus, Cucumis myriocarpus, Ekebergia capensis, Prunus 
africana, Protea caffra, Searsia lancea and Solanum panduriforme were selected (Figures 2.1-
2.7). The ethnomedicinal uses of these plants are summarized in Table 2.1. 
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Table 2.1: Ethnomedicinal applications of seven South African traditional medicinal plants as recorded in the current literature. 
Species, authority 
Family 
Part 
used 
Voucher 
number 
Traditional uses References 
Bolusanthus speciosus (Bolos) Harms 
Fabaceae 
Bark NU0042512 Abdominal pains, emetic and tuberculosis PALGRAVE (1977) 
Bark 
Leaves 
Stems 
 Blood cleansing, kidney ailments and sexually 
transmitted infections 
MAGOBO (1990) 
Roots  Emetic and abdominal pains AMUSAN et al. (2002) 
VENTER AND VENTER (2002) 
Cucumis myriocarpus (Naud) E. Mey 
Curcubitaceae 
Fruits NU0042511 Gonorrhoea and syphilis SEMENYA et al. (2013a) 
Ekebergia capensis Sparrm 
Maliaceae 
Bark 
 
 
NU0042516 Malaria, tonic, chronic coughs, headaches, 
dysentery, boils, dermatological diseases, 
laxative, emetic, sexually-transmitted diseases 
HUTCHINGS et al. (1996) 
GRIERSON AND AFOLAYAN (1999) 
KOCH et al. (2005) 
Prunus africana (Hook) Kalkman 
Rosaceae 
Stems 
Bark 
NU0042513 Allergies, diarrhoea, gastrointestinal ailments, 
kidney and prostate gland diseases 
PUJOL (1990) 
Leaves  Abdominal pains, laxative, skin diseases, 
prostatitis 
GANGOUE-PIEBOJI et al. (2009) 
Not 
specified 
 Anti-inflammatory, aphrodisiac, appetite 
stimulants, chest pains, heart burn, fevers, 
kidney ailments, madness, malaria, urinary 
tract infections, wound dressing 
NEUWINGER (2000) 
NDENECHO (2009) 
Protea caffra Meisn 
Proteaceae 
Bark NU0048533 Bleeding stomach ulcers and diarrhoea COETZEE AND LITTLEJOHN (2000) 
Roots  Healing broken bones ZUKULU (2012) 
Seed  Chlamydia SEMENYA et al. (2013a) 
Searsia lancea Barley 
Anacardiaceae 
Wood NU0042514 Skin tanning WATT AND BREYER-BRANDWIJK (1962) 
Leaves  Colds, fever, papules and pustules HUTCHINGS et al. (1996) 
Roots  Diarrhoea and gall sickness VAN DER MERWE et al. (2001) 
Solanum panduriforme E. Mey 
Solanaceae 
Fruits NU0042515 Gonorrhoea and wounds BRUSCHI et al. (2011) 
ERASMUS et al. (2012) 
Roots  Diarrhoea, ingestion, pelvic pains, stomach 
aches, snake bites, tooth aches and ulcers 
BRUSCHI et al. (2011) 
HUTCHINGS et al. (1996) 
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2.1.1. Bolusanthus speciosus Harms 
2.1.1.1. Botany and ethnomedicinal applications 
B. speciosus belongs to the Fabaceae family and is the only known member of the genus 
Bolusanthus (ERASTO et al., 2004). This deciduous tree which grows up to 10 m in height is 
indigenous to Africa’s Sub-Saharan regions where it thrives mainly on bushveld with alkaline 
soils (VAN WYK AND VAN WYK, 1997). In South Africa, this tree is locally known as tree 
wisteria (English); vanwykshout (Afrikaans); mogaba (Northern Sotho); motsokophala 
(Tswana); mukambana (Venda) and umholo (Zulu) (ELISHA et al., 2015). In Limpopo, South 
Africa, the bark, leaves and stems of B. speciosus are commonly used by the VhaVenda people 
to treat kidney and venereal diseases (MAGOBO, 1990). Root infusions are also used as an 
emetic, while the stem bark is used to manage abdominal pains, emetism and tuberculosis 
(PALGRAVE, 1977).  
 
2.1.1.2. Ethnopharmacology and phytochemistry 
Several studies validated the traditional use of B. speciosus. For instance, 
MULAUDZI et al. (2011) revealed and confirmed that the plant has potent antibacterial activities 
against pathogens that cause abdominal pains and gonorrhoea. The authors also revealed that 
the plant has noteworthy antifungal and anti-HIV properties MULAUDZI et al. (2013) 
demonstrated that B. speciosus stems have potent anti-inflammatory activities. In other studies, 
organic solvent extracts from the leaves of B. speciosus exhibited strong inhibitory effects 
against the growth of Bacillus anthracis (ELISHA et al., 2015) and weak antimycobacterial 
activities (ELISHA et al., 2017). 
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Figure 2.1: Bolusanthus speciosus growing in the Botanical Garden, University of KwaZulu-
Natal, Pietermaritzburg, South Africa. 
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Some of the compounds isolated from B. speciosus (Table 2.2.) have been demonstrated to 
have noteworthy antimicrobial activities. BOJASE et al. (2001b) used the Thin Layer 
Chromatography (TLC) bioautography technique to investigate the antibacterial properties of 
flavonoids isolated from the stem bark. The authors observed that both 4,7,2C-trihydroxy-4C-
methoxy isoflavanol and 5,7,3C,4C-tetrahydroxy-5C-(2-epoxy-3-methylbutyl) isoflavanone 
had weak activities against Gram-positive (Bacillus subtilis, Staphylococcus aureus) and 
Gram-negative (Escherichia coli) bacterial strains. Based on the agar overlay technique, 
Bolusanthin II, 5,7,2′,4′-tetrahydroxy-8,3′-di(γ,γ-dimethylallyl) isoflavanone, 5,7,2′-
trihydroxy-4′- methoxy-6,5′-diprenylisoflavanone and 5,7,4′- trihydroxy-6,3′- di (γ,γ-
dimethylallyl) isoflavanone has good activities against B. subtilis and S. aureus, as well as 
moderate inhibitory activities against E. coli, Candida mycoderma and Saccharomyces 
cerevisiae (BOJASE et al., 2002). Bolusanthin III, Bolusanthin IV and Isogacaonine also have 
noteworthy antimicrobial and antioxidant activities (ERASTO et al., 2004).  
 
Although the chemistry and biological activities of B. speciosus are well documented, the 
synergistic interactions between its extracts and antibiotics, as well as the efficacy of these 
extracts and their bioactive constituents against drug-resistant bacterial strains remains largely 
unknown. 
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Table 2.2: Putative bioactive compounds isolated from different organs of Bolusanthus speciosus as recorded in the current literature. 
 
Plant 
organ 
Compound Chemical 
group 
Reference 
Leaves 11α-allycytisine, anagyrine, 5,6-dehydrolupanine, 13-hydroxyanagyrine, ß-iso-parteine, 
lupanine, N-methylcytisine, sparteine 
Alkaloids ASRES et al. (1986) 
Root bark Bolucarpan A-D, bolusanthin II  Flavonoids BOJASE et al. (2001b) 
Root bark Bolusanthin II,   
bolucarpan A, bolucarpan B, bolucarpan D 
Flavonoids 
Ptero-carpans 
BOJASE et al. (2002) 
Root wood Bolusanthin III, bolusanthin IV, derrone, 7,3’-dihydroxy-4’-methoxyisoflavone, 
gancaonin C, genistein, 7-hydroxy-4-methoxyisoflavone, isogancaonin C, 
lupiwighteone, medicarpan, wighteone 
Flavonoids ERASTO et al. (2004) 
Seeds Biochanin, bolusanthin, genistein, orobol, pratensein, 3’-O-methylorobol, 3-O-
methylpratensein 
Flavonoids ASRES et al. (1985) 
Stem bark Bolusanthols A-C Flavonoids BOJASE et al. (2001a) 
Stem bark 5,7,3’-trihydroxy-4’-methoxy-5’-ƴ,ƴ-dimethylallylisoflavanone, 5,7,2’-trihydroxy-4’-
methoxy-6,5’-di(ƴ,ƴ-dimethylallyl) isoflavanone, 5,7,2’,4’-tetrahydroxy-8,3’di(ƴ,ƴ-
dimethylallyl) isoflavanone 4,2,3’,4’-tetrahydroxy-6,7- methylenedioxyisoflavonol, 
4,7,2’-trihydroxy-4’-methoxyisoflavanol, derrone, 5,7,3’,4’- tetrahydroxy-5’-ƴ,ƴ-
dimethylallyl-isoflavanone, 5,7,4’-trihydroxy-6,3’-di(ƴ,ƴ-dimethylallyl) isoflavanone, 
5,7,3’,4’-tetrahydroxy-5’-(2,3-epoxy-3-methylbutyl) isoflavanone 
Flavonoids BOJASE et al. (2001b) 
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2.1.2. Cucumis myriocarpus Naud 
2.1.2.1. Botany and ethnomedicinal applications 
C. myriocarpus Naud is an annual climber which flowers in summer and grows up to 2 m in 
length (SHAIK et al., 2011). This scandent herb is a member of the Curcubitaceae family and 
has two subspecies: subsp. leptodermis (Schweick.) found only in South Africa, and subsp. 
myriocrpus which is found in different parts of the world (KIRKBRIDE, 1993). In South Africa, 
this plant is commonly known as the bitter apple, wild cucumber (English), agurkie, 
bitterappeltjie, komkommertjie (Afrikaans) and sendelenja (Zulu)  (HUTCHINGS et al., 1996).  
 
A survey by SEMENYA et al. (2013c) revealed that the Bapedi people of South Africa use the 
fruits of this plant to treat gonorrhoea and syphilis. Fruits are also used to treat boils and as a 
purgative or emetic agent (MOTEETEE AND VAN WYK, 2011; USMAN et al., 2015). However, 
the plant contains high concentration of toxic cucurbitacins (SIMMONDS et al., 2000; 
MASHELA et al., 2008) and as such, extreme caution should be taken when using this herb as 
a vegetable (NKGAPELE AND MPHOSI, 2012) or when administering it to patients. Research 
indicates that consumption of the plant often leads to photosensitization in sheep and blindness 
in cattle (MCKENZIE et al., 1988; SIMMONDS et al., 2000; KESSELL et al., 2015). Over 
dosages of root and ripe fruit decoctions may also lead to sudden death in humans (BOTHA AND 
PENRITH, 2008). 
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Figure 2.2: Cucumis myriocarpus growing in the Botanical Garden, University of KwaZulu-
Natal, Pietermaritzburg, South Africa. The insert shows the fruit of C. myriocarpus. 
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2.1.2.2. Ethnopharmacology and phytochemistry  
Compared to other African traditional medicinal plants, the ethnobotanical applications of wild 
cucumber are quite restricted, perhaps due to its bitterness and toxicity. Cucurbitacins which 
are highly concentrated in the roots and fruits are among some of the bitterest substance known 
to man (POFU et al., 2010). The fruits also contain elevated quantities of curcumin, 
leptodermin, as well as cucurbitin A and D which are highly toxic 
(MASHELA, 2002; MPHAHLELE et al., 2012).  
 
The potential use of this plant as a bionematicide has been extensively investigated (MASHELA, 
2002; MAFEO AND MASHELA, 2010; POFU et al., 2010). However, a review of the current 
literature indicates that only one study (MUEDI, 2005) was conducted to assess the 
pharmacological properties of C. myriocarpus. The authors reported that the fruits have 
anthelmintic properties as well as inhibitory effects against Bacillus litcheniformis, Bacillus 
laterosporus and Bacillus chitinosporus (MIC range: 0.78-3.13 mg/ml). Further studies are 
warranted to particularly validate the traditional uses of this medicinal plant, as well as to 
identify the bioactive compounds it produces. 
 
2.1.3. Ekebergia capensis Sparrm 
2.1.3.1. Botany and ethnomedicinal applications 
The genus Ekebergia consists of African trees belonging to the Trichiliae tribe of the Meliaceae 
family (MULHOLLAND AND IOURINE, 1998). E. capensis is a fairly large deciduous tree (60 m 
tall) native to Africa’s tropical and subtropical regions (POOLEY, 1993; HEMP, 2006). In South 
Africa, this tree is known locally as the Cape-ash (English), essenhout (Afrikaans), mmidibidi 
(Nothern Sotho) and umnyamati (Zulu) (GRIERSON AND AFOLAYAN, 1999; SMITH et al., 
2010; GRAINGER et al., 2011). 
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The Cape-ash is used widely in African traditional medicine. For instance, the Zulu people of 
South Africa use stem wood decoctions as an oxytocic agent, while root decoctions are used to 
treat acne, boils, coughing, dysentery, gastritis, hyperacidity and sores (WATT AND BREYER-
BRANDWIJK, 1962; PUJOL, 1990). In Kenya, the Sabaot herbalists use leaf macerations to 
manage headaches, fevers, coughing and skin diseases, while the Agĩkũyũ and Kikuyu 
traditional healers use the stem bark and roots to treat diarrhoea (IRUNGU et al., 2014). Kenyans 
also use the stem bark to manage gonorrhoea and tuberculosis (KIMUTAI et al., 2015). In 
different parts of Africa, the plant is used to treat several ailments including malaria, chest 
pains, respiratory infections and also, as a purgative parasiticide (WATT AND BREYER-
BRANDWIJK, 1962; HUTCHINGS et al., 1996; MUREGI et al., 2004; IRUNGU et al., 2014). 
 
2.1.3.2. Ethnopharmacology and phytochemistry 
The traditional uses of E. capensis are, to some extent, substantiated by empirical evidence. 
Leaf extracts of the plant have inhibitory activities against Cryptococcus neoformans 
(MIC = 0.4 mg/ml), a fungi that cause respiratory infections (YORK et al., 2012). LALL AND 
MEYER (1999) also demonstrated that acetone extracts from the bark have noteworthy 
activities against both drug-resistant and -sensitive Mycobacterium tuberculosis strains. The 
plant also has potent antifungal, antigonococcal (MULAUDZI et al., 2011) and broad-spectrum 
antibacterial properties (RABE AND VAN STADEN, 1997; KIMUTAI et al., 2015). Apart from 
antimicrobial properties, work by other researchers revealed that the plant also has noteworthy 
antihypertensive (KAMADYAAPA et al., 2009), antimalarial(CLARKSON et al., 2004; 
MUREGI et al., 2004; IRUNGU et al., 2014) and antiviral properties (BAGLA et al., 2012). 
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Figure 2.3: Ekebergia capensis growing in the Botanical Garden, University of KwaZulu-
Natal, Pietermaritzburg, South Africa. 
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Although empirical evidence suggests that E. capensis has extended-spectrum antibacterial 
activities, the principal bioactive compounds remain largely unknown. Some phytochemical 
studies on this plant, however, revealed the presence of limonoids and triterpenoids  
(Table 2.3), some of which demonstrated promising antiplasmodial properties  
(NISHIYAMA et al., 1996; MULHOLLAND AND IOURINE, 1998; MURATA et al., 2008). These 
compounds have, however, not yet been evaluated for antibacterial and other pharmacological 
properties. 
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Table 2.3: Putative bioactive compounds isolated from different organs of Ekebergia capensis as recorded in the current literature.  
Plant 
organ 
Compounds Chemical 
group 
References 
Stem bark Ekeberin D4, D5,  
(3R,22R)-2,3,22,23-tetrahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-
tetracosatetraene, 
(2R,3R,22R)-2-hydroxymethyl-2,3,22,23-tetrahydroxy-2,6,10,15,19,23-hexamethyl-
6,10,14,18-tetracosatetraene 
 
 
Triterpenoids 
 
 
 
 
MURATA et al. (2008) 
  
Stem bark 
 
7-deacetoxy-7-oxogedunin  
Ekeberin C1-C3 
 
Limonoids 
Seeds Capensolactones l-3 Limonoids MULHOLLAND AND 
IOURINE (1998) 
Stem bark 2,3,22,23-tetrahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetrae ne and 2-
hydroxymethyl-2,3,22,23-tetrahydroxy-6,10,15,19,23-pentamethyl-6,10,14,18- 
tetracosatetraene  
Acyclic 
triterpenoids 
NISHIYAMA et al. (1996) 
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2.1.4. Prunus africana (Hook. F.) Kalkman 
2.1.4.1. Botany and ethnomedicinal applications 
In South Africa, P. africana is commonly known as the African almond, African cherry, bitter 
almond (English), bitteramandelhout, nuweamandelhout, rooi-stinkhout, wilde-kersieboom,  
(Afrikaans), inkokhokho, inyazangoma-elimnyama, ngubozinyeweni, umlalume (Zulu), 
inyazangoma, umkhakhazi (Xhosa and Zulu) and mulala-maanga (TshiVhenda) (PALMER AND 
PITMAN, 1961; POOLEY, 1993). This dicotyledonous, evergreen and highland forest tree  
(30-40 m tall) belongs to the Rosaceae family and thrives mostly in tropical and subtropical 
islands and countries across the African and American continents (BRENAN, 1978). In South 
Africa, isolated populations of the African almond are found in the Eastern Cape, Free State, 
Gauteng, Kwazulu-Natal, North West, Limpopo and Mpumalanga provinces 
(SCOTT-SHAW, 1999). 
 
P. africana plays a very significant role in South African folk medicine so much that there are 
growing concerns that the plant may soon be extinct due to overexploitation (GANGOUE-
PIEBOJI et al., 2009). Traditional healers prescribe different parts of the plant to manage fevers, 
malaria, stomach pains, kidney diseases, high blood pressure, allergies, prostate gland disease, 
insanity and as a purgative agent (STEWART, 2003; BII et al., 2010). This plant is also used 
traditionally to treat diseases that are known or suspected to be caused by bacterial infections 
such as diarrhoea, inflammations, gonorrhoea, dermatological, respiratory and urethral tract 
infections (GANGOUE-PIEBOJI et al., 2009). According to SHENOUDA et al. (2007), the plant 
is also used by African traditional medical practitioners to manage different types of cancer.  
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Figure 2.4: A specimen photograph of Prunus africana courtesy of http://sizeofwales.org.uk.  
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2.1.4.2. Ethnopharmacology and phytochemistry  
Although P. africana leaves are used widely in folk medicine, it seems most pharmacological 
studies focused mainly on screening its stem bark for antimicrobial activities.  
ELDEEN et al. (2005) demonstrated that ethanol extracts of the bark and leaves have noteworthy 
inhibitory activities against both Gram-positive (B. subtilis and S. aureus) and Gram-negative 
(E. coli and K.  pneumoniae) bacterial strains. Ethanol extracts of the bark also exhibited 
noteworthy activities against ß-lactam-resistant Enterococcus hirae and Staphylococcus 
saprophyticus with MIC values of 0.6 and 0.3 mg/ml, respectively (GANGOUE-PIEBOJI et al., 
2009). Studies by BII et al. (2010) provided further empirical evidence suggesting that the plant 
has antibacterial compounds effective against drug-resistant bacterial strains. The authors 
demonstrated that methanolic extracts of the bark had good inhibitory activities against drug-
sensitive S. aureus, Trichophyton mentagrophyte, Pseudomonas aeruginosa and methicillin-
resistant S. aureus (MIC range: 0.039-0.156 mg/ml). They also observed that the same extracts 
(methanol bark) were not active against Cryptococcus neoformans and Candida albicans. 
MWITARI et al. (2013) confirmed some of these results and postulated that the responsible 
bioactive compounds had bactericidal and immunopotentiation effects.  
 
Prostate gland hypertrophy and benign prostrate hyperplasia (BPH) are manageable using 
commercially available medicines prepared from P. africana root and stem bark extracts 
(SUNDERLAND AND OBAMA, 1999; SCHIPPMANN et al., 2002). Pharmacological and 
phytochemical studies indicates that these barks contain phytosterols (an anti-inflammatory 
agent that inhibit the accumulation of proinflammatory prostaglandins in the prostate), 
pentacyclic triterpenes (anti-edema or decongesting action) and ferulic esters of long chain 
fatty alcohols (lowers the level of prolactin and inhibit the accumulation of cholesterol in the 
prostate) (BOMBARDELLI AND MORAZZONI, 1997). The plant also produces another anti-BPH 
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compound known as myristic acid (HASS et al., 1999). Phytochemical studies by  
NTUBA-JUA et al. (2018) and NGULE et al. (2014) revealed the presence of tannins, flavonoids, 
terpenoids, saponins, phenolics and steroids in P. africana barks. The presence of these 
compounds could probably justify the traditional use of the plant to treat different bacterial 
infections. 
 
P. africana has several ethnomedicinal applications and hence is a potential source of different 
bioactive molecules. While the plant’s anti-BPH properties are well documented, little is 
currently known about its antibacterial compounds. Research indicates that there is much 
potential in discovering antibacterial compounds effective against both drug-resistant and  
-sensitive bacterial strains from this medicinal plant (GANGOUE-PIEBOJI et al., 2009;  
BII et al., 2010).  
 
2.1.5. Protea caffra Meisn 
2.1.5.1. Botany and ethnomedicinal applications 
P. caffra is a dicotyledonous shrub that flowers in summer and has an average height of 3 m 
(DU PREEZ AND VENTER, 1990). In South Africa, it is known as the common sugarbush, Natal 
sugarbush, highveld protea (English), gewone suikerbos, waboom, (Afrikaans), isadlunge, 
indlunge, isiqwanwe (Isixhosa), uhlinkihane (Zulu) tshididiri, tshidzungu (TshiVhenda), 
mahlako, mogalagala, segwapi, sekila and tshidzungu (Sotho) (PATERSON-JONES, 2000, 2007; 
RAIMONDO et al., 2009; WYBENGA, 2010). The common sugarbush grows mainly on rocky or 
mountainous south-facing slopes of the northern and eastern parts of South Africa and has also 
encroached into some parts of Mozambique and Zimbabwe (STRUGNELL, 2002;  
BAMFORD et al., 2010).  
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The bark of P. caffra is used by some South Africa traditional healers to treat bleeding stomach 
ulcers and diarrhoea (COETZEE AND LITTLEJOHN, 2000). Warm infusions of the stem bark 
and root bark are taken orally or in the form of enemas to treat diarrhoea (RAIMONDO et al., 
2009). According to ZUKULU (2012), the roots are used to prepare umhlabelo, a decoction used 
to help heal broken bones. The fruit and bark are used to relieve people from dizziness, while 
dried seeds are used in decoctions to manage different psychological disorders (VAN WYK AND 
GERICKE, 2000). According to SEMENYA et al. (2013b), P. caffra seeds are also used to treat 
chlamydia, a sexually transmitted disease.   
 
2.1.5.2. Ethnopharmacology and phytochemistry 
Literature review indicates that the pharmacological properties and phytochemical profiles of 
P. caffra are currently unknown. Extensive pharmacological studies are warranted to ascertain 
if the traditional uses of this plant are based on mere folklore or its bioactive secondary 
metabolites.  
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Figure 2.5: Protea caffra growing in the Walter Sisulu National Botanical Garden, 
Johannesburg, South Africa.  
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2.1.6. Searsia lancea (L.f) Barkley 
2.1.6.1. Botany and ethnomedicinal applications 
S. lancea (synonym Rhus lancea) belongs to the mango family, Anacardiaceae, which is the 
fourth largest tree family in southern Africa (VAN WYK AND VAN WYK, 1997). In South Africa, 
this plant is known locally as ‘karee’ (Afrikaans and English), ‘moshabele’ (seTswana) and 
‘umhlakotshane’ (Xhosa) (VAN DER MERWE et al., 2001; LANGE et al., 2012; KABONGO‐
KAYOKA et al., 2016) and in north America as the ‘Africa sumac’ (KARLIK AND WINER, 2001). 
This evergreen tree can achieve a height of 7 m and grows mainly in temperate and tropical 
regions around the world (RAYNE AND MAZZA, 2007).  
 
S. lancea has a wide range of ethnobotanical applications in South Africa. The Basotho people, 
for example, use the leaves and fruits to manage diabetes, skin infections, herpes sores 
(SELETENG KOSE et al., 2015), dizziness due to anemia, heart problems and high blood 
pressure (NAIR et al., 1983; AGANGA AND MOSASE, 2001; MOTEETEE AND  
VAN WYK, 2011). The leaves are also used traditionally to treat fevers, colds, headache, 
papules and pustules (MAGOBO, 1990). The Thiaping people on the other hand use the stem 
wood for tanning purposes (WATT AND BREYER-BRANDWIJK, 1962).  
 
2.1.6.2. Ethnopharmacology and phytochemistry 
Extracts from S. lancea have been shown to demonstrate a wide range of pharmacological 
properties. MAYEKISO et al. (2009) observed that the leaves have good anti-mycobacterial 
properties. The bark and roots have noteworthy antibacterial and anthelmintic properties 
(MCGAW et al., 2007). MULAUDZI et al. (2012) demonstrated that the leaves have potent 
antibacterial and anti-inflammatory properties.  
 
 
23 
 
 
Figure 2.6: Searsia lancea growing in the Botanical Garden, University of KwaZulu-Natal, 
Pietermaritzburg, South Africa.  
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Several members of the Searsia genus are used in folk medicine around the world (RAYNE AND 
MAZZA, 2007; AHMED et al., 2014) and literature strongly suggests that this genus is a 
potential rich source of novel anti-infection agents (RAYNE AND MAZZA, 2007;  
AHMED et al., 2014). Given the widespread traditional use of karee, it is conceivable that this 
plant may contain a wide range of novel pharmacological compounds. 
 
2.1.7. Solanum panduriforme E. Mey 
2.1.7.1. Botany and ethnomedicinal applications 
S. panduriforme is a small, perennial herbal plant that shares the same family (Solanaceae) 
with tomatoes, potatoes and tobacco (RAIMONDO et al., 2009). This herb has an average height 
of 0.5 m and flowers in summer (PLOWES AND DRUMMOND, 1990; BURROWS AND WILLIS, 
2005). According to KIRBY (2013), the local South African names given to this plant include 
bitter apple (English), bitterappel (Afrikaans), mohato, setlwanwe, morolane (Setswana), 
intuma, intumemcane (Zulu) and ndulwane (Tsonga). In South Africa, the bitter apple is mainly 
found in the Free State, Gauteng, North West, KwaZulu-Natal, Limpopo and North West 
provinces (HUTCHINGS et al., 1996).  
 
The bitter apple has important ethnoveterinary and ethnobotanical applications in South Africa. 
In the Free State, the fruit sap from this plant, known locally as mohato, is used to relieve cattle 
of diarrhoea (VAN DER MERWE et al., 2001). In folk medicine, however, the fruits are used to 
treat wounds, while roasted and ground roots are used to treat several gastrointestinal ailments 
such as diarrhoea, chronic pain, ingestion and ulcers (BRUSCHI et al., 2011). Chewing the root 
helps to relieve pelvic pains, while roasted roots and fruit sap decoctions are used to manage 
toothaches (HUTCHINGS et al., 1996). The Bapedi people reportedly manage toothaches by 
burning the plant’s fruits and inhaling the smoke (SEMENYA et al., 2013b). A survey by 
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ERASMUS et al. (2012) revealed that macerated fruit decoctions are used in Limpopo to treat 
gonorrhoea. 
 
2.1.7.2. Ethnopharmacology and phytochemistry  
Although S. panduriforme is used widely in South African traditional medicine to treat 
bacterial infections, studies indicate that the plant generally has weak antibacterial activities. 
STEENKAMP et al. (2007) reported that the methanol extracts from the fruits of  
S. panduriforme exhibited weak inhibitory activity against Staphylococcus epidermidis and no 
active against S. aureus. Studies by MORE et al. (2008) also indicated that extracts from the 
roots of this plant which, as indicated above, are used to manage toothache did not have any 
inhibitory activities on several pathogens that cause human oral health diseases namely 
Actinobacillus actinomycetemcomitans, Actinomyces naeslundii, Actinomyces israilii,  
C. albicans, Porphyromonus gingivalis, Privotella intermedia and Streptococcus mutans. 
Additionally, GREEN et al. (2010) found that the plant had very weak anti-mycobacterial 
activities (MIC ≥ 10 mg/ml). However, using the disk-diffusion technique, 
MULAUDZI et al. (2015) demonstrated that the plant has potent antigonococcal properties (74% 
inhibition). This plant could therefore be further explored as a potential source of 
antigonococcal molecules.  
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Figure 2.7: A specimen picture of Solanum panduriforme courtesy of www.ispotnature.org.  
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2.2. Antimicrobial resistance and the essence of combination therapy  
The misuse and widespread use of antibiotics in medicine have caused several pathogenic 
bacterial strains to mutate and acquire additional survival strategies (POOLE, 2001). These 
bacterial mutations have often instigated the evolution of several kinds of antibiotic resistant 
bacterial strains which are now a menace to public health globally. Particularly, multidrug-
resistant (MDR) bacterial strains remain a serious cause of concern since they cause treatment 
failures and impose huge economic burdens especially in developing countries  
(DE ANGELIS et al., 2014; BALLANI AND BABBY, 2016). This predicament is exacerbated by 
the precipitous rate at which antibiotic resistant bacterial strains are evolving which far 
surpasses the rate at which new antibiotics are being developed (COATES et al., 2002). Unlike 
the ‘Golden era’ of antibiotic discovery (mid 1940s-early 1970s) during which several classes 
of antibiotics were discovered, only two new classes of antibiotics were developed in the last 
40 years (SINGH AND BARRETT, 2006; MUNDY et al., 2016). Furthermore, there is also an 
increasing concern that newly developed antibiotics might have shorter life spans because most 
MDR mutants often resist the effects of the antibiotics they have been previously exposed to 
as well as other chemically similar or unrelated antibacterial agents 
(COATES et al., 2002).  
 
Most MDR bacterial infections can successfully be managed using combination therapies. As 
a result, modern therapeutic regimes usually consist of combinations of antibiotics with other 
antibiotics, non-bactericidal chemicals or plant extracts (WILLIAMSON, 2001;  
ANDRIES et al., 2005). Combination therapies are often favoured in cases where the combined 
antibacterial effects of two antibacterial agents used in a given combination supersedes the sum 
effects of either agent used alone (KHAN et al., 2009). Apart from curtailing the growth and 
development of antimicrobial resistant mutants, synergistic therapies are known to potentiate 
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the efficacy of antibiotics, increase the antibacterial spectrum and the bioavailability of 
antibacterial agents into bacterial cells (ZHAO et al., 2002; TRIPODI et al., 2007; 
CHUKWUJEKWU AND VAN STADEN, 2016).  
 
A few years ago, GANDHI et al. (2006) discovered Mycobacterium tuberculosis strains resistant 
to all known antibiotics in KwaZulu-Natal, South Africa, which perhaps served as early 
warning signs of an imminent ‘untreatable bacterial infections’ era. The need to accelerate the 
rate at which novel therapeutic drugs are being developed cannot therefore, be overemphasized. 
Thus, researchers including ethnobotanists should strive to, among other things, discover more 
clinically relevant highly efficacious antibacterial compounds and novel antibacterial 
resistance modifying compounds from natural sources especially plants. Given that some 
medicinal plants such as Berberis fremontii have been reported to produce both bactericidal 
compounds and antibacterial resistance inhibitors (STERMITZ et al., 2000), understanding the 
intricate nature of combination therapies involving medicinal plant extracts will inevitably help 
achieve these two important research goals.   
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CHAPTER 3: Antibacterial screening 
 
3.1. Introduction 
Alkaloids, flavonoids, essential oils, phenolic acids, saponins and tannins are amongst some of 
the high-value phytocompounds responsible for the therapeutic properties of several medicinal 
plant extracts (WALLACE, 2004; ERDELYI et al., 2005; KULKARNI AND DHIR, 2010; 
CHANDRASEKARA AND SHAHIDI, 2011; XIAO et al., 2011). The presence and concentration of 
these bioactive compounds often vary from one taxonomic group to the other, within organs of 
the same plant and seasonally (LONGANGA et al., 2000; VAN HEERDEN et al., 2003; 
 SICILIANO et al., 2004; LUCKNER, 2013). Compelling empirical evidence also indicates that 
medicinal plants with distinctively unique chemical compositions can have similar 
pharmacological properties (MULAUDZI et al., 2011; ERASMUS et al., 2012). Additionally, 
some medicinal plants are used to treat a wide range of both infectious and non-infectious 
maladies (MAGOBO, 1990; HUTCHINGS et al., 1996; NEUWINGER, 2000). This obviously 
explains why medicinal plants form an integral part of the Materia medica utilised in both folk 
and conventional medicine. 
 
The exploitation of South Africa’s extensive floral diversity (GERMISHUIZEN AND MEYER, 
2003), with respect to medical bioprospecting, could lead to the discovery of numerous 
antibacterial molecules with clinical significance. The current study was designed to evaluate 
the in vitro antibacterial properties of extracts from seven South African traditional medicinal 
plants. 
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3.2. Materials and methods 
3.2.1. Plant collection 
The plant materials were collected between July and September 2015. B. speciosus, 
E. capensis, P. africana and S. lancea were collected from the University of KwaZulu-Natal 
(UKZN) Pietermaritzburg (PMB) Botanical garden, while P. caffra was collected from the 
Walter Sisulu South African National Biodiversity Institute (SANBI) (27o 50´ 40.7´´ E 26o 
05´13.8´´S). Seeds of C. myriocarpus and S. panduriforme were obtained from Bradfield, 
Bulawayo, Zimbabwe (20o 10´40´´S 28o 35´ 06´´ E) and grown in the UKZN PMB Botanical 
garden. The selected plants were positively identified by the Curator (University of KwaZulu-
Natal Bews Herbarium), after which voucher specimens were prepared and deposited in the 
UKZN Bews Herbarium. The voucher specimen numbers are presented in Table 2.1. Once 
collected, the plant materials were oven dried for 3-5 days at 50 oC, ground and stored in brown 
paper bags at room temperature.  
 
3.2.2. Source of chemicals 
Organic solvents (dichloromethane, methanol, and petroleum ether) were purchased from 
Radchem laboratory supplies (PTY) Ltd (Alberton, South Africa). The antibiotics and 
dimethylsulfoxide (DMSO) were supplied by Sigma-Aldrich Co. (Steinheim, Germany). 
Carbon dioxide generator, chocolate agar, Mueller and Hinton (MH) growth medium (broth 
and agar), soluble haemoglobin, and Vitox were bought from Oxoid Ltd (Hampshire, United 
Kingdom).  
 
3.2.3. Extraction of plant for biological activities 
At a ratio of 10:1 (10 ml/g), dry powdered samples were mixed with different solvents (water, 
methanol = MeOH, dichloromethane = DCM, and petroleum ether = PE) and stirred in a rotary 
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shaker (Edmund Bühler, Tübingen, German) for 12 h at 150 rpm at room temperature, after 
which they were sonicated for 1 h on ice (Julabo GMBH, Germany). Organic solvent extracts 
were filtered using Whatman No. 1 filter paper under vacuum and later concentrated using a 
rotary evaporator (Heldolph vv 2000, Germany) at 35 oC. Concentrated organic solvent extracts 
were transferred into glass pill vials and air-dried in front of a fan. All water extracts were 
freeze-dried. The resulting 64 dried extracts were kept in closed glass pill vials in the dark at 
10 oC until required for further use.  
 
3.2.4. Antigonococcal activity 
3.2.4.1. Preparations of gonococcal stocks 
A loopful of Neisseria gonorrhoeae American type culture collection (ATCC) 49226 stored at 
-70 oC was inoculated into 5 ml Mueller Hinton (MH) broth and incubated overnight at 
37 oC in an orbital shaker water bath (50 rpm). Two microliters of the overnight culture were 
spread uniformly on sterile chocolate agar (Oxoid GC agar base), supplemented with  
2% (w/v) haemoglobin together with 1% (v/v) of Vitox, and incubated in 5% carbon dioxide 
(CO2) incubators for 24 h at 37 
oC. The plates were then kept at 4 
oC and the gonococcal stocks 
sub-cultured once every month to maintain bacterial cell viability.  
 
3.2.4.2. Disk-diffusion bioassay 
The disk-diffusion technique (CLSI, 2009) was used to determine the antigonococcal activities 
of the 64 plant extracts. Five milliliters of sterile MH broth were inoculated with a colony of 
N. gonorrhoeae and incubated overnight at 37 oC in an orbital shaker water bath (50 rpm). Two 
microliters of the diluted overnight cultures [≈ 5 x 105 colony forming units per milliliter 
(cfu/ml)] were then spread uniformly on chocolate agar and incubated in  
5% CO2 incubators for 24 h at 37 
oC. Stock sample solutions were prepared by resuspending 
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samples in 20% DMSO to a concentration of 100 mg/ml. The working sample solutions were 
made by diluting the stock solutions with sterile distilled water to a concentration of 
10 mg/ml. Five microliters of each resuspended plant extract (10 mg/ml) were impregnated 
onto sterile Whatman filter paper disks (6 mm diameter) and dried under a stream of sterile air. 
Ciprofloxacin (0.5 µg/disk) was used as a positive control, while 5 µl of distilled water and  
5 µl of 2% DMSO served as the negative controls. The impregnated disks were then aseptically 
placed on top of the N. gonorrhoeae cultures growing on chocolate agar and incubated in 5% 
CO2 incubators for 24 h at 37 
oC. The assay was repeated twice, in quadruplicate for each 
sample. 
 
Plant extracts with antigonococcal properties were indicated by the appearance of clear zones 
of bacterial growth inhibition around each disk after a 24 h incubation. The efficacy of each 
plant extract was then determined by comparing the diameters of the test plant extract with the 
positive control and expressing them as inhibition percentages, as shown below; 
 
Percentage (%) inhibition = (Diameter of the sample ÷ diameter of positive control)×100 
 
The results were expressed as average inhibition percentage ± standard error. The greater the 
inhibition percentage, the more efficacious the plant extract was considered to be.  
3.2.4.3. Antigonococcal microdilution bioassay 
Minimum inhibitory concentration (MIC) values of the 64 plant extracts were determined using 
96-well microplates (Greiner Bio-one, Germany) as previously described by ELOFF (1998). A 
colony of N. gonorrhoeae was inoculated into 5 ml sterile MH broth and incubated overnight 
at 37 oC in an orbital shaker water bath (50 rpm). One hundred microliters of each resuspended 
plant extract (10 mg/ml) were 2-fold serially diluted with sterile water, in triplicate, down a  
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96-well microplate. A similar 2-fold serial dilution of ciprofloxacin (1 mg/ml) was used as a 
positive control, while sterile distilled water and 2% DMSO were used as the negative controls. 
One hundred microliters of diluted bacterial cultures were then added to each well to give a 
final inoculum of approximately 5 x 105 cfu/ml and then incubated in 5% CO2 incubators for 
24 h at 37 oC. Bacterial growth was detected by adding 50 µl of 0.2 mg/ml  
p-iodonitrotetrazolium chloride (INT) to each well and the plates incubated for 1 h at 37 oC. 
Bacterial growth was indicated by a red-pink colour, whereas clear wells indicated inhibition 
of bacterial growth by the test plant extract. MIC values were recorded as the lowest 
concentration of the extract showing a clear well. To confirm results, the assay was repeated 
twice. 
 
3.2.5. Antibacterial activity 
3.2.5.1. Bacterial stock preparation 
Bacterial stocks were cultured on MH agar. A colony of each strain was inoculated into 5 ml 
sterile MH broth and incubated overnight at 37 oC in an orbital shaker water bath (50 rpm). 
Twenty milliliters of hot sterile MH agar were transferred into each petri dish, allowed to cool 
and set. Each test bacterial stock strain (overnight cultures) was then streaked on MH agar and 
incubated at 37 oC for 24 h. The plates were stored at 4 oC and the bacterial stocks sub-cultured 
monthly to maintain bacterial cell viability. 
 
 3.2.5.2. Microdilution bioassay 
Minimum inhibitory concentration (MIC) values of extracts from seven traditional medicinal 
plants were determined using 96-well microplates (Greiner Bio-one, Germany) as previously 
described by ELOFF (1998). A colony of each bacterial strain was inoculated into 5 ml sterile 
MH broth and incubated overnight at 37 oC in an orbital shaker water bath (50 rpm). One 
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hundred microliters of each resuspended sample (10 mg/ml) were 2-fold serially diluted with 
sterile water, in triplicate, down a 96-well microplate. A similar 2-fold serial dilution of 
neomycin (0.1 mg/ml) was used as a positive control against each test bacterial strain (E. coli 
ATCC 11775, Enterococcus faecalis ATCC 19433 , Klebsiella pneumoniae ATCC 13883, 
MDR E. coli ATCC 25218, MDR K. pneumoniae ATCC 70603, drug-sensitive S. aureus 
ATCC 12600 and penicillin-resistant S. aureus ATCC 11632). Sterile MH broth, distilled water 
and 2% DMSO were used as the negative controls. One hundred microliters of each diluted, 
test bacterial strain were added to each well to give a final inoculum of approximately  
5x105 cfu/ml, after which the plates were covered with parafilm and incubated for 24 h at 
37 oC. The detection of bacterial growth and interpretation of results were done as described in 
Section 3.2.4.3 above. The assay was done twice to confirm the results. 
 
3.2.6. Antibacterial synergy 
3.2.6.1. Checkerboard titration method 
The antibacterial interactions of different plant extract combinations, as well as combinations 
of plant extracts with antibiotics (ampicillin, cefotaxime, chloramphenicol and penicillin) were 
assessed in 96-well microplates using the 8 x 8 microdilution checkerboard analysis technique 
(RAND et al., 1993). Fifty microliters of water were added to each well after which 50 µl of 
plant extract X were added in row A and serially diluted down to row I. Fifty microliters of 
plant extract Y or a given antibiotic were added in decreasing concentrations from column 1 to 
8. Once the test antibacterial agents were mixed together, each microplate well was then 
inoculated with 100 µl of the test bacterial strain (MDR E. coli, MDR  
K. pneumoniae or N. gonorrhoeae), to give a final inoculum of approximately 5 x 105 cfu/ml. 
The plates were covered with parafilm and incubated for 24 h at 37 oC. However, in the case 
of N. gonorrhoeae, incubation was done in 5% CO2 incubators for 24 h at 37
 oC, during which 
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the microplates were not covered with parafilm. For each combination, the fractional inhibitory 
concentration index (FICI) was calculated as follows: FICI = FICX + FICY, where FICX was the 
MIC of antibacterial agent X when used in combination with antibacterial agent Y, divided by 
the MIC of antibacterial agent X when used alone. The results were interpreted thus;  
FICI ≤ 0.5 (synergy); 0.5 < FICI ≤ 1.0 (additive) and 1.0 < FICI ≤ 4.0 (no interaction) and  
FICI > 4.0 (antagonism) (VAN VUUREN AND VILJOEN, 2011). 
 
3.2.6.2. Time-kill bioassay 
Time-kill assays for plant extract + antibiotic combinations that demonstrated noteworthy 
antibacterial synergism using the checkerboard assay were performed using the broth 
microdilution technique (WHITE et al., 1996). This assay was done thrice, in triplicate for each 
sample. Sterile MH broth was used as the negative control, while test plant extracts and 
antibiotics were each used as the positive controls. After the antibiotic and plant extract were 
mixed in their respective ratios, 500 µl of the mixture were then added to 500 µl of MH broth 
in a sterile Eppendorf tube and a 2-fold serial dilution of the mixture performed to obtain the 
MIC and 0.5 x MIC. Five hundred microliters of the test bacterial strain were then added to 
give a final inoculum of approximately 5 x 105 cfu/ml. The inoculum was then incubated for 
90 min at 37 oC in an orbital shaker water bath (50 rpm). Ten microliter aliquots were taken 
from the inoculum after incubation, added to 990 µl of sterile MH broth and serially diluted 
(100 fold) in MH broth. Twenty-five microliters of the final dilution were plated on MH 
nutrient agar to determine the 0 h counts. This procedure was repeated at 3, 6 and 24 h after 
the 0 h viable colony counts were taken and the plates were incubated for 24 h at 37 oC. The 
mean viable colony counts (cfu/ml) were expressed as log10 units. A 2 log10 difference in mean 
cfu between the positive control (antibiotic) and a given antibacterial combination was 
considered indicative of noteworthy synergistic interactions between the test antibacterial 
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agents used in the combination mixture. Data were presented as mean ± standard error of the 
triplicate determinants.  
 
3.3. Results and discussion 
3.3.1. Antigonococcal activity 
The intricate chemo-diversity found in phytocompounds, position medicinal plants as 
impeccable sources for novel pharmaceutical drugs. Against this background, medicinal plant 
extracts were screened in the current study for antigonococcal activity using two traditional 
antibacterial susceptibility testing methods, namely the disk-diffusion and microdilution 
techniques. Based on the agar disk-diffusion assay, all 64 tested plant extracts did not 
demonstrate antigonococcal activities at the tested concentration(s). However, when the same 
extracts were screened using the microdilution assay, four plant extracts, namely S. lancea 
DCM leaf extracts (MIC = 0.313 mg/ml), B. speciosus MeOH and DCM bark extracts  
(MIC’s = 0.625 mg/ml) and P. africana leaf DCM extracts (MIC = 0.625 mg/ml), demonstrated 
moderate antigonococcal activities (Table 3.1). The difference observed in the results obtained 
from these two bioassays could be attributed to several factors. A scrutiny of these results 
reveals that antibacterial activity was not observed in the disk-diffusion assay due to either a 
total lack of antigonococcal property in some of the tested plant extracts or that the antibacterial 
activity was masked. The latter could have been due to the use of a plant extract concentration 
(10 mg/ml) that was too low to effect notable antigonococcal activities. Although the disk-
diffusion technique is one of the inexpensive and less laborious antibacterial susceptibility 
testing methods currently available (RELLER et al., 2009), this procedure suffers with the 
demerit of not always producing reproducible results for several plant extracts (ELOFF, 1998). 
This is primarily because some phytochemicals, especially non-polar ones, do not diffuse 
readily in polarized agarose gels (RIOS et al., 1988). Hence, bioactive compounds in  
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B. speciosus, S. lancea and P. africana plant extracts probably failed to diffuse through the 
chocolate agar during the disk-diffusion incubation period to effect noticeable antigonococcal 
activity. This in turn probably led to the pseudo-negative results observed. 
 
The antigonococcal property of B. speciosus has previously been reported 
(MULAUDZI et al., 2011). Based on the available literature, this is the first report on the 
antigonococcal properties of S. lancea and P. africana. These two are classic examples of 
plants, not only with extended-spectrum antibacterial activities, but also having sundry 
pharmacological activities (PUJOL, 1990; MCGAW et al., 2007; KADU et al., 2012;  
MULAUDZI et al., 2012). Such plants obviously owe their extensive pharmacological properties 
to their rich array of bioactive compounds. The current study provides vital scientific 
information that could be utilised by traditional healers to especially, improve the provision of 
rural primary health care. Instead of using the usual herbal preparations from plants such as 
Callilepis salicifolia, Jatropha zeyheri, Cotyledon orbiculata, Catharanthus roseus and Senna 
italica to manage gonorrhoea (ERASMUS et al., 2012), herbalists could now alternatively use 
the leaves of S. lancea and P. africana. This could perhaps be one of the rare incidences in 
which such vital ethnobotanical information flows from the scientists to herbalists, more often 
than not, it is the other way around. The use of several alternative plant species to manage 
gonorrhoea does not only help delay the development of pathogenic drug-resistance, but also 
helps to conserve our biodiversity by preventing the over-exploitation of one or a few popular 
traditional medicinal plant species known to have antigonococcal properties. 
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Table 3.1: Minimum inhibition concentration (MIC, mg/ml) values of extracts obtained from 
seven South African traditional medicinal plants against Neisseria gonorrhoeae. 
Plant species Plant Organ MIC (mg/ml) 
  Water MeOH DCM PE 
Bolusanthus speciosus Bark >2.5 0.625  0.625  2.5  
Cucumis myriocarpus Fruits >2.5  >2.5 >2.5 >2.5 
 Roots >2.5  >2.5 >2.5 >2.5 
 Leaves >2.5  >2.5 >2.5 >2.5 
Ekebergia capensis Leaves >2.5  >2.5 >2.5 >2.5 
Prunus africana Leaves >2.5 2.5 0.625 2.5 
 Twigs >2.5  >2.5 >2.5 >2.5 
Protea caffra Bark >2.5  >2.5 >2.5 >2.5 
 Flowers >2.5  >2.5 >2.5 >2.5 
 Leaves >2.5  >2.5 >2.5 >2.5 
 Seeds >2.5  >2.5 >2.5 >2.5 
 Twigs >2.5  >2.5 >2.5 >2.5 
Searsia lancea Leaves >2.5 2.5 0.313 2.5 
Solanum panduriforme Fruits >2.5  >2.5 >2.5 >2.5 
 Roots >2.5  >2.5 >2.5 >2.5 
 Stems >2.5  >2.5 >2.5 >2.5 
 
DCM= Dichloromethane, MeOH = Methanol; PE = Petroleum ether. 
*MIC values bold-written are considered to have noteworthy antigonococcal activity. 
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3.3.2. Antibacterial activity 
Indigenous knowledge often provides important leads in the discovery of novel pharmaceutical 
drugs. In the present study extracts from seven South African medicinal plants selected based 
on their ethnomedicinal uses were screened for antibacterial activities against a panel of seven 
bacterial strains. The antibacterial MIC values of all test plant extracts are presented in Table 
3.2. Plant extracts were classified as having significant (MIC ≤ 0.1 mg/ml),  
moderate (100<MIC≤ 0.625 mg/ml) or weak (MIC >0.625 mg/ml) antibacterial activities 
according to KUETE (2010). The most potent antibacterial activity was therefore exhibited by 
the MeOH extracts of B. speciosus bark which achieved MIC values of  
0.039 and 0.078 mg/ml against S. aureus (penicillin-resistant and drug-sensitive, respectively). 
Since season and climate have a bearing on the chemical profiles of most plants  
(KADU et al., 2012), it is imperative that further studies be conducted to ascertain if the 
antibacterial properties displayed by B. speciosus in the present study were due to the 
compounds previously isolated by BOJASE et al. (2002) and ERASTO et al. (2004). The MeOH 
leaf extracts of S. lancea, as well as PE seed extracts of P. caffra also yielded moderate 
antibacterial activities against S. aureus (MIC = 0.12 mg/ml) and E. coli (MIC = 0.25 mg/ml), 
respectively. Ten other plant extracts also achieved noteworthy activity (MIC = 0.31 mg/ml) 
against different test bacterial strains including the penicillin-resistant S. aureus (Table 3.2).  
 
DCM leaf extracts of S. lancea yielded an MIC value of 0.63 mg/ml against five of the seven 
test bacterial strains including MDR E. coli and MDR K. pneumoniae. B. speciosus bark 
(MeOH and DCM), P. caffra seeds (DCM) and twigs (MeOH) as well as S. lancea leaves 
(MeOH) also demonstrated extended-spectrum antibacterial properties. The present findings 
indicate that medicinal plant extracts could potentially be used to manage a wide range of 
infections caused by both Gram-positive and Gram-negative MDR bacterial strains. Medicinal 
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plants with potent, broad-spectrum antibacterial properties such as B. speciosus could serve as 
new sources of novel antimicrobial compounds in the near future. If fully exploited, such 
medicinal plants could therefore play a crucial role in addressing the prevalent pharmaceutical 
drug shortages. Interestingly, P. caffra, an ornamental plant rarely used in folk medicine, also 
demonstrated noteworthy antibacterial activity. Notably, most organic solvent seed extracts 
from this plant showed promising activity against E. coli and K. pneumoniae (Gram-negative 
strains) with MIC values in the range of 0.25-0.63 mg/ml (Table 3.2). The moderate 
antibacterial activities exhibited by P. caffra in the current study could perhaps explain the use 
of its seeds to manage chlamydia (a bacterial infection) by some traditional healers in South 
African (SEMENYA AND POTGIETER, 2014). P. caffra as well as the whole Proteaceae family 
and Protea genus should be fully explored as potential sources of medicinally important 
antibacterial compounds.  
 
In the present investigation, 50% of the screened plant extracts demonstrated noteworthy 
activities against the Gram-positive E. faecalis making this the most susceptible bacterial 
strain. The least susceptible bacterial strain was however, MDR K. pneumoniae. Gram-negative 
bacterial strains have thick hydrophilic peptidoglycan layers which impedes the influx of most, 
especially hydrophobic, antibacterial agents into their cells (REECE et al., 2011). 
Consequently, Gram-negative bacterial strains are generally less susceptible to antibacterial 
agents than Gram-positive strains which are characterized by thinner peptidoglycan layers. It 
was therefore notable that, of the 64 plant extracts evaluated only S. lancea leaf DCM and 
MeOH extracts displayed moderate activities against Gram-negative, MDR K. pneumoniae 
(MIC’s = 0.63mg/ml). In addition, S. lancea was the only one, out of the seven test plants, that 
demonstrated noteworthy activity against most Gram-negative bacterial strains (E. coli,  
K. pneumoniae, MDR K. pneumoniae). 
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All aqueous extracts evaluated in the present study had MIC values >2.5 mg/ml and were 
therefore excluded in Table 3.2. It is not, however, uncommon for aqueous extracts to exhibit 
no antibacterial activities during bioassays yet aqueous decoctions and infusions are widely 
used in folk medicine. This is largely because during most ethnobotanical studies plant extracts 
are prepared under highly controlled laboratory conditions which are often quite different from 
the conditions under which traditional medicines are prepared. Boiling, mixing different herbs, 
as well as mixing herbs with non-plant materials during preparations of traditional medicines 
often activate and/or increase the bioavailability of phytocompounds in the extract (CANO AND 
VOLPATO, 2004; AZIZAH et al., 2009). Additionally, it is a well-known fact that the principal 
bioactive compounds in some medicinal plant extracts are not necessarily microbiocidal or 
microbiostatic in nature, but rather immune-regulators which generally boost the human 
immune system and hence help it fight pathogenic invasions (JEONG et al., 2003;  
ZWICKEY et al., 2007; KHODADADI, 2016). 
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Table 3.2: Minimum inhibitory concentration values (MIC, mg/ml) of medicinal plant extracts screened against drug-sensitive and -resistant 
bacterial strains. 
Family 
Species 
Plant  
organ 
MIC (mg/ml) 
 
  MeOH DCM 
  Ec Ef Kp Sa Ec D Kp D Sa D Ec Ef Kp Sa Ec D Kp D Sa D 
Fabaceae 
Bolusanthus 
speciosus 
 
Bark 
 
2.5 
 
0.31 
 
1.25 
 
0.078 
 
0.63 
 
1.25 
 
0.039 
 
2.5 
 
0.31 
 
2.5 
 
0.078 
 
2.5 
 
2.5 
 
0.078 
Curcubitaceae 
Cucumis 
myriocarpus 
 
Fruits 
 
1.25 
 
0.63 
 
2.5 
 
1.25 
 
>2.5 
 
>2.5 
 
>2.5 
 
2.5 
 
1.25 
 
2.5 
 
1.25 
 
>2.5 
 
>2.5 
 
1.25 
 Leaves  >2.5 2.5 >2.5 >2.5 >2.5 >2.5 >2.5 >2.5 1.25 >2.5 >2.5 >2.5 >2.5 >2.5 
 Roots >2.5 2.5 >2.5 2.5 >2.5 2.5 >2.5 2.5 1.25 >2.5 2.5 2.5 2.5 2.5 
Maliaceae 
Ekebergia 
capensis 
 
Leaves 
 
2.5 
 
2.5 
 
>2.5 
 
>2.5 
 
2.5 
 
>2.5 
 
2.5 
 
2.5 
 
0.31 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
Proteaceae 
Protea caffra 
 
Bark 
 
1.25 
 
0.63 
 
>2.5 
 
0.31 
 
>2.5 
 
>2.5 
 
>2.5 
 
1.25 
 
>2.5 
 
2.5 
 
1.25 
 
>2.5 
 
2.5 
 
1.25 
 Flowers 1.25 1.25 1.25 2.5 2.5 2.5 2.5 1.25 0.63 1.25 0.63 2.5 1.25 >2.5 
 Leaves 2.5 0.63 1.25 1.25 2.5 2.5 0.63 2.5 >2.5 1.25 2.5 >2.5 2.5 2.5 
 Seeds 0.63 1.25 0.31 1.25 1.25 2.5 1.25 0.63 0.63 0.31 1.25 2.5 1.25 1.25 
 Twigs 1.25 0.31 0.63 0.31 1.25 1.25 0.63 2.5 2.5 2.5 2.5 >2.5 >2.5 >2.5 
Rosaceae 
Prunus africana 
 
Leaves 
 
2.5 
 
0.63 
 
1.25 
 
1.25 
 
1.25 
 
2.5 
 
0.63 
 
2.5 
 
>2.5 
 
1.25 
 
2.5 
 
0.63 
 
2.5 
 
2.5 
 Twigs 2.5 0.63 1.25 0.31 2.5 2.5 0.31 2.5 2.5 >2.5 2.5 2.5 2.5 2.5 
Anacardiaceae 
Searsia lancea 
 
Leaves 
 
1.25 
 
0.63 
 
1.25 
 
0.12 
 
1.25 
 
0.63 
 
1.25 
 
1.25 
 
0.63 
 
0.63 
 
0.63 
 
0.63 
 
0.63 
 
1.25 
Solanaceae 
Solanum 
panduriforme 
 
Fruits 
 
1.25 
 
2.5 
 
2.5 
 
1.25 
 
>2.5 
 
2.5 
 
1.25 
 
2.5 
 
0.63 
 
2.5 
 
>2.5 
 
>2.5 
 
>2.5 
 
2.5 
 Leaves >2.5 2.5 >2.5 2.5 >2.5 >2.5 2.5 >2.5 2.5 2.5 1.25 >2.5 >2.5 >2.5 
 Roots 1.25 2.5 1.25 >2.5 2.5 1.25 1.25 1.25 0.63 1.25 1.25 2.5 1.25 1.25 
 Stems 2.5 2.5 2.5 >2.5 >2.5 >2.5 2.5 1.25 >2.5 >2.5 1.25 >2.5 >2.5 >2.5 
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Table 3.2: Continued. 
 
Ec = Escherichia coli; Ef = Enterococcus faecalis; Kp = Klebsiella pneumoniae; 
Sa = Staphylococcus aureus; Ec D = Multidrug resistant E. coli; Kp D = Multidrug-resistant 
K. pneumoniae, Sa D = Penicillin resistant S. aureus. 
*MIC values bold-written indicate noteworthy antibacterial activity. 
 
Family 
Species 
Plant 
organ 
 MIC (mg/ml) 
     PE    
  Ec Ef Kp Sa Ec D Kp D Sa D 
Fabaceae 
Bolusanthus speciosus 
 
Bark 
 
2.5 
 
>2.5 
 
>2.5 
 
>2.5 
 
>2.5 
 
>2.5 
 
>2.5 
Curcubitaceae 
Cucumis myriocarpus 
 
Fruits 
 
2.5 
 
1.25 
 
2.5 
 
1.25 
 
>2.5 
 
>2.5 
 
2.5 
 Leaves 2.5 2.5 >2.5 1.2 >2.5 >2.5 >2.5 
 Roots 2.5 2.5 >2.5 2.5 >2.5 >2.5 2.5 
Maliaceae 
Ekebergia capensis 
 
Leaves 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
>2.5 
 
>2.5 
Proteaceae 
Protea caffra 
 
Bark 
 
2.5 
 
0.63 
 
2.5 
 
2.5 
 
2.5 
 
2.5 
 
>2.5 
 Flowers 1.25 0.31 1.25 0.63 2.5 1.25 2.5 
 Leaves 2.5 >2.5 1.25 0.63 2.5 2.5 2.5 
 Seeds 0.25 2.5 1.25 2.5 2.5 1.25 2.5 
 Twigs 2.5 2.5 2.5 2.5 2.5 1.25 1.25 
Rosaceae 
Prunus africana 
 
Leaves 
 
2.5 
 
>2.5 
 
1.25 
 
0.63 
 
2.5 
 
2.5 
 
2.5 
 Twigs >2.5 >2.5 >2.5 >2.5 >2.5 >2.5 >2.5 
Anacardiaceae 
Searsia lancea 
 
Leaves 
 
2.5 
 
2.5 
 
1.25 
 
0.47 
 
1.25 
 
1.25 
 
0.63 
Solanaceae 
Solanum panduriforme 
 
Fruits 
 
>2.5 
 
1.25 
 
>2.5 
 
2.5 
 
>2.5 
 
>2.5 
 
1.25 
 Leaves >2.5 2.5 >2.5 2.5 >2.5 >2.5 2.5 
 Roots 2.5 >2.5 2.5 2.5 2.5 >2.5 >2.5 
 Stems >2.5 1.25 2.5 2.5 >2.5 >2.5 >2.5 
Neomycin (positive control) µg/ml 1.56 >100 1.56 0.39 6.25 6.25 25 
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3.3.3. Antibacterial synergy  
Understanding the antibacterial synergistic interactions in medicinal plant-based combination 
therapies will undoubtably provide important leads in the discovery of novel antibacterial 
resistance modifying compounds from plants. In the current study, the antibacterial synergistic 
interactions within different plant extracts, as well as between plant extracts and antibiotics 
were investigated. The evaluated microbial strains were indeed multidrug-resistant (Table 3.3) 
given that the MIC breakpoints for all tested antibiotics used in this study against E. coli and 
K. pneumoniae were > 8 µg/ml (EUCAST, 2016). The FICI values of all the antibacterial 
combinations evaluated in this study are presented in Tables 3.4-3.6. All plant extract 
combinations evaluated against N. gonorrhoeae (Table 3.4) yielded FICI values greater than 
0.5 and hence exhibited no synergistic interactions (VAN VUUREN AND  
VILJOEN, 2011). Similarly, all plant extract + antibiotic combinations screened against the 
MDR K. pneumoniae showed no antibacterial synergistic interactions (Table 3.5).  
Both N. gonorrhoeae and K. pneumoniae are typical Gram-negative bacterial strains which, as 
already alluded to, are comparatively less susceptible to antibacterial agents than Gram-
positive bacterial strains.  
 
However, 3 out of 32 combinations (antibiotic + plant extract) evaluated against the MDR 
E. coli demonstrated noteworthy antibacterial synergism with FICI values ranging from 
0.38 to 0.5 (Table 3.6). It is interesting to note that in all three combinations there was a 
4-7.8-fold reduction in the MIC values of the test antibiotic (chloramphenicol). This 
observation indicated that in all these combinations, certain plant extract constituents made the 
test bacterial strain much more susceptible to chloramphenicol. These bioactive compounds 
together with chloramphenicol probably exerted multi-target effects on the test bacterial strain. 
Chloramphenicol inhibits bacterial protein synthesis resulting in the premature death of 
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bacterial cells (SIIBAK et al., 2009). Some antibacterial agents however, inhibit bacterial cell 
wall formation, while others block important metabolic pathways such as those involved in 
DNA replication, RNA synthesis and reproduction (CHANDA AND RAKHOLIYA, 2011). 
Chances are also that chloramphenicol and the bioactive compounds found in the tested plant 
extracts had similar antibacterial mechanisms. Hence the two antibacterial agents probably 
made the test bacterial strain more vulnerable by preventing the formation of several important 
bacterial proteins such as enzymes, cytochromes and DNA-binding proteins.  
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Table 3.3: Minimum inhibitory concentration (MIC, mg/ml) values of selected plant extracts 
and *antibiotics against the multidrug-resistant (MDR) strains of Escherichia coli and 
Klebsiella pneumoniae. 
 MIC mg/ml 
Plant extract MDR E. coli MDR K. pneumoniae 
Bolusanthus speciosus bark MeOH 0.625 1.25 
Protea caffra flower DCM  NT 1.25 
Protea caffra flower PE  NT 1.25 
Protea caffra seed DCM NT 1.25 
Protea caffra seed MeOH 1.25 NT 
Protea caffra seed PE NT 1.25 
Protea caffra twig MeOH 1.25 1.25 
Protea caffra twig PE NT 1.25 
Prunus africana leaf DCM 0.625 NT 
Prunus africana leaf MeOH 1.25 NT 
Searsia lancea leaf DCM 0.625 0.625 
Searsia lancea leaf MeOH 1.25 0.625 
Searsia lancea leaf PE 1.25 0.625 
Solanum panduriforme root DCM NT 1.25 
Solanum panduriforme root MeOH NT 1.25 
*Ampicillin 5 5 
*Cefotaxime 0.02 0.3 
*Chloramphenicol 0.156 0.3 
*Penicillin 0.625 5 
 
DCM= Dichloromethane, MeOH = Methanol, PE= Petroleum ether, NT = Not tested. 
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Table 3.4: Antigonococcal synergistic interactions among different plant extract 
combinations. 
 
Plant  MIC (mg/ml) FIC FICI Outcome 
Combinations Individual Combination    
Palm + Bsbm  2.5/ 0.625 2.5/ 0.125 1/ 0.25 1.25 No interaction 
Palm + Bsbd  2.5/ 0.625 1.25/ 0.313 0.5/ 0.5 1 Additive 
Palm + Bsbp 2.5/ 2.5 1.25/ 0.625 1/ 0.002 1.002 Additive 
Palm + Sllm 2.5/ 2.5 2.5/ 0.005 1/0.002 1.002 Additive 
Palm + Slld  2.5/ 0.313 1.25/ 0.313 0.5/ 1 1.5 No interaction 
Palm + Sllp 2.5/ 2.5 0.625/ 2.5 0.25/ 1 1.25 No interaction 
Pald + Bsbm 0.625/ 0.625 0.125/ 0.313 0.2/ 0.5 0.7 Additive 
Pald + Bsbd 0.625/ 0.625 0.313/ 0.313 0.5/ 0.5 1 Additive 
Pald + Bsbp 0.625/ 2.5 0.625/ 0.313 1/ 0.125 1.1 No interaction 
Pald + Sllm 0.625/ 2.5 0.039/ 2.5 0.06/ 1 1.1 No interaction 
Pald + Slld 0.625/ 0.313 0.156/ 0.156 0.25/ 0.5 0.75 Additive 
Pald + Sllp 0.625/ 2.5 0.313/ 1.25 0.5/ 0.05 0.6 Additive 
Palp + Bsbm 2.5/ 0.625 2.5/ 0.6 1/ 1 2 No interaction 
Palp + Bsbd 2.5/ 0.625 0.625/ 0.625 0.25/ 1 1.25 No interaction 
Palp + Bsbp 2.5/ 2.5 1.25/ 1.25 0.5/ 0.5 1 Additive 
Palp + Sllm 2.5/ 2.5 1.25/ 2.5 0.5/ 1 1.5 No interaction 
Palp + Slld 2.5/ 0.313 1.25/ 0.078 0.5/ 0.25 0.75 Additive 
Palp + Sllp 2.5/ 2.5 2.5/ 0.005 1/ 0.002 1 Additive 
Sllm + Bsbm 2.5/ 0.625 2.5/ 0.156 1/ 0.25 1.25 No interaction 
Sllm + Bsbd 2.5/ 0.625 0.625/ 0.625 0.25/ 1 1.25 No interaction 
Sllm + Bsbp 2.5/2.5 2.5/1.25 1/0.5 1.5 No interaction 
Slld + Bsbm 0.313/ 0.625 0.156/ 0.156 0.5/ 0.25 0.75 Additive 
Slld + Bsbd 0.313/0 .625 0.156/ 0.078 0.5/ 0.13 0.625 Additive 
Slld + Bsbp 0.313/2.5 0.078/2.5 0.25/1 1.25 No interaction 
Sllp + Bsbm 2.5/ 0.625 2.5/ 0.156 1/ 0.25 1.25 No interaction 
Sllp + Bsbd 2.5/ 0.625 2.5/ 0.315 1/ 0.5 1.5 No interaction 
Sllp + Bsbp 2.5/2.5 2.5/0.315 1/ 0.126 1.13 No interaction 
 
Bsbd = Bolusanthus speciosus bark dichloromethane extract, Bsbm = Bolusanthus specious 
bark methanol extract, Bsbp = Bolusanthus specious bark petroleum ether extract, 
Pald = Prunus africana leaf dichloromethane extract, Palm = Prunus africana leaf methanol 
extract, Palp = Prunus africana leaf petroleum ether, Slld = Searsia lancea leaf 
dichloromethane, Sllm = Searsia lancea leaf methanol extract, Sllp = Searsia lancea leaf 
petroleum ether, FIC = fractional inhibition concentration, FICI = fractional inhibition 
concentration index, MIC = minimum inhibition concentration. 
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Table 3.5: Antibacterial interactions within combinations of selected conventional antibiotics 
and plant extracts against multidrug-resistant Klebsiella pneumoniae. 
Antibacterial 
combinations 
MIC (mg/ml) FIC FICI  Outcome 
 Individual Combination    
Bsbm + Amp 1.25/ 5 0.625/ 2.5 0.5/ 0.5 1 Additive 
Bsbm + Cef 1.25/ 0.313 0.625/ 0.078 0.5/ 0.25 0.75 Additive 
Bsbm + Chl 1.25/ 0.313 0.625/ 0.078 0.5/ 0.25 0.75 Additive 
Bsbm + Pen  1.25/ 5 1.25/ 1.25 1/ 0.25 1.25 No interaction 
Pcfd + Amp 1.25/ 5 0.313/ 5 0.25/ 1 1.25 No interaction 
Pcfd + Cef  1.25/ 0.313 0.625/ 0.157 0.5/ 0.5 1 Additive 
Pcfd + Chl 1.25/ 0.313 0.313/ 0.313 0.25/ 1 1.25 No interaction 
Pcfd + Pen 1.25/ 5 1.25/ 0.313 1/ 0.06 1.06 No interaction 
Pcfp + Amp 1.25/ 5 1.25/ 2.5 1/ 0.5 1.5 No interaction 
Pcfp + Cef 1.25/ 0.313 0.313/0.157 0.25/0.52 0.77 Additive 
Pcfp + Chl 1.25/ 0.313 1.25/ 0.313 1/ 1 2 No interaction 
Pcfp + Pen  1.25/ 5 0.6/ 2.5 0.48/ 0.5 0.98 Additive 
Pcsd + Amp  1.25/ 5 0.156/ 5 0.12/ 1 1.12 No interaction 
Pcsd + Cef 1.25/ 0.313 1.25/ 0.039 1/ 0.125 1.13 No interaction 
Pcsd + Chl 1.25/ 0.313 0.039/ 0.313 0.031/ 1 1.03 Additive 
Pcsd + Pen 1.25/ 5 0.625/ 5 0.5/ 1 1.5 No interaction 
Pcsp + Amp 1.25/ 5 0.625/ 0.625 0.5/ 0.13 0.625 Additive 
Pcsp + Cef 1.25/ 0.313 0.313/ 0.313 0.25/ 1 1.25 No interaction 
Pcsp + Chl 1.25/ 0.313 0.625/ 0.157 0.5/ 0.5 1 Additive 
Pcsp + Pen 1.25/ 5 1.25/ 0.313 1/ 0.06 1.06 No interaction 
Pctm + Amp 1.25/ 5 0.625/ 5 0.5/ 1 1.5 No interaction 
Pctm + Cef 1.25/ 0.313 1.25/ 0.02 1/ 0.06 1.06 No interaction 
Pctm + Chl 1.25/ 0.313 0.313/ 0.157 0.25/ 0.5 0.75 Additive 
Pctm + Pen 1.25/ 5 1.25/ 0.313 1/ 0.06 1.06 No interaction 
Pctp + Amp  1.25/ 5 1.25/ 0.625 1/ 0.12 1.12 No interaction 
Pctp + Cef 1.25/ 0.313 1.25/ 0.001 1/ 0.003 1 Additive 
Pctp + Chl 1.25/ 0.313 0.039/ 0.313 0.031/ 1 1.03 Additive 
Pctp + Pen 1.25/ 5 0.313/ 2.5 0.25/ 0.5 0.75 Additive 
Sllm + Amp 0.625/ 5 0.039/ 5 0.06/ 1 1.06 No interaction 
Sllm + Cef 0.625/ 0.313 0.158/ 0.157 0.25/ 0.5 0.75 Additive 
Sllm + Chl 0.625/ 0.313 0.02/ 0.313 0.03/ 1 1.03 Additive 
Sllm + Pen 0.625/ 5 0.313/ 1.25 0.5/ 0.2 0.7 Additive 
Slld + Amp 0.63/ 5 0.313/ 2.5 0.5/ 0.5 1 Additive 
Slld + Cef 0.63/ 0.313 0.313/ 0.313 0.5/ 1 1.5 No interaction 
Slld + Chl 0.63/ 0.313 0.63/ 0.313 1/ 1 2 No interaction 
Slld + Pen 0.63/ 5 0.16/ 5 0.25/ 1 1.25 No interaction 
Sllp + Amp 0.63/ 5 0.315/ 5 0.5/ 1 1.5 No interaction 
Sllp + Cef 0.63/ 0.313 0.63/ 0.039 1/ 0.1 1.12 No interaction 
Sllp + Chl 0.63/ 0.313 0.315/ 0.157 0.5/ 0.5 1 Additive 
Sllp + Pen 0.63/ 5 0.16/ 2.5 0.25/ 0.5 0.75 Additive 
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Table 3.5: Continued. 
Antibacterial 
combinations 
MIC (mg/ml) FIC FICI Outcome 
 Individual Combination    
Sprd + Amp 1.25/ 5 0.313/ 5 0.25/ 1 1.25 No interaction 
Sprd + Cef 1.25/ 0.313 0.625/ 0.078 0.5/ 0.25 0.75 Additive 
Sprd + Pen 1.25/ 5 0.313/ 2.5 0.25/ 0.5 0.75 Additive 
Sprm + Amp 1.25/ 5 1.25/ 5 0.5/ 1 1.5 No interaction 
Sprm + Cef 1.25/ 0.313 0.313/ 0.57 0.25/ 0.5 0.75 Additive 
Sprm + Chl 1.25/ 0.6 0.625/ 0.157 0.5/ 0.52 1.02 Additive 
Sprm + Pen 1.25/ 5 0.625/ 5 0.5/ 1 1.25 No interaction 
 
Bsbm= Bolusanthus speciosus bark methanol extract, Pcfd = Protea caffra flower 
dichloromethane extract, Pcsd = Protea caffra seed dichloromethane extract, Pcsp = Protea 
caffra seed petroleum ether extract, Pctm = Protea caffra twig methanol extract, 
Pctp = Protea caffra twig petroleum ether extract, Slld = Searsia lancea leaf dichloromethane 
leaf extract, Sllm = Searsia lancea leaf methanol extract, Sllp = Searsia lancea leaf petroleum 
ether extract, Amp = ampicillin, Cef = cefotaxime, Chl = chloramphenicol,  
Pen = penicillin, FIC =  Fractional inhibition concentration, FICI = Fractional inhibition 
concentration index, MIC = minimum inhibition concentration. 
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Table 3.6: Antibacterial interactions within combinations of selected conventional antibiotics 
and plant extracts against multidrug-resistant Escherichia coli. 
Antibacterial 
combinations 
MIC (mg/ml) FIC FICI Outcome 
 Individual Combination    
Bsbm + Amp 0.625/ 5 0.313/ 2.5 0.5/ 0.5 1 Additive 
Bsbm + Cef 0.625/ 0.002 0.625/ 0.001 1/ 0.5 1.5 No interaction 
Bsbm + Chl 0.625/ 0.156 0.156/ 0.02 0.25/ 0.125 0.375 Synergy 
Bsbm + Pen 0.625/ 0.625 0.625/ 0.313 1/ 0.5 1.5 No interaction 
Pcsm + Amp 1.25/ 5 0.625/ 5 0.5/ 1 1.5 No interaction 
Pcsm + Cef 1.25/ 0.002 0.625/ 0.001 0.5/ 0.5 1 Additive 
Pcsm + Chl 1.25/ 0.156 1.25/ 0.156 1/ 1 2 No interaction 
Pcsm + Pen 1.25/ 0.625 0.313/ 0.625 0.25/ 1 1.25 No interaction 
Pctm + Amp 1.25/ 5 0.625/ 1.25 0.5/ 0.25 0.75 Additive 
Pctm + Cef 1.25/ 0.002 0.078/ 0.002 0.062/ 1 1.06 No interaction 
Pctm + Chl 1.25/ 0.156 0.039/ 0.156 0.031/ 1 1.03 No interaction 
Pctm + Pen 1.25/ 0.625 0.156/ 0.313 0.125/ 0.5 0.625 Additive 
Palm + Amp  1.25/ 5 0.156/ 2.5 0.125/ 0.5 0.625 Additive 
Palm + Cef 1.25/ 0.002 0.625/ 0.002 0.5/ 1 1.5 No interaction 
Palm + Chl 1.25/ 0.156 0.313/ 0.02 0.25/ 0.128 0.378 Synergy 
Palm + Pen 1.25/ 0.625 1.25/ 0.313 1/ 0.5 1.5 No interaction 
Pald + Amp 0.625/ 5 0.625/ 1.25 1/ 0.25 1.25 No interaction 
Pald + Cef 0.625/ 0.002 0.313/ 0.002 0.5/ 1 1.5 No interaction 
Pald + Chl 0.625/ 0.156 0.156/ 0.039 0.25/ 0.25 0.5 Synergy 
Pald + Pen 0.625/ 0.625 0.313/ 0.625 0.5/ 1 1.5 No interaction 
Sllm + Amp 1.25/ 5 1.25/ 0.078 1/ 0.016 1.02 No interaction 
Sllm + Cef 1.25/ 0.002 1.25/ 0.001 1/ 0.5 1.5 No interaction 
Sllm + Chl 1.25/ 0.156 0.625/ 0.078 0.5/ 0.5 1 Additive 
Sllm + Pen 1.25/ 0.625 1.25/ 0.313 1/ 0.5 1.5 No interaction 
Slld + Amp 0.625/ 5 0.625/ 0.156 1/ 0.031 1.03 No interaction 
Slld Cef 0.625/ 0.002 0.156/ 0.002 0.25/ 1 1.25 No interaction 
Slld + Chl 0.625/ 0.156 0.625/ 0.001 1/ 0.006 1.01 No interaction 
Slld + Pen 0.625/ 0.625 0.039/ 0.625 0.062/ 1 1.06 No interaction 
Sllp + Amp 1.25/ 5 0.313/ 2.5 0.25/ 0.5 0.75 Additive 
Sllp + Cef 1.25/ 0.002 0.039/ 0.002 0.031/ 1 1.03 No interaction 
Sllp + Chl 1.25/ 0.156 1.25/ 0.078 1/ 0.5 1.5 No interaction 
Sllp + Pen 1.25/ 0.625 0.156/ 0.625 0.125/ 1 1.13 No interaction 
Bsbm = Bolusanthus speciosus bark methanol extract, Pcsm = Protea caffra seed methanol 
extract, Pctm = Protea caffra seed methanol extract, Palm = Prunus africana leaf methanol 
extract, Pald = Prunus africana leaf dichloromethane extract, Slld = Searsia lancea leaf 
dichloromethane extract, Sllm = Searsia lancea leaf dichloromethane extract, Sllp = Searsia 
lancea leaf petroleum ether extract, Amp = ampicillin, Cef = cefotaxime, 
Chl = chloramphenicol, Pen = penicillin, FIC = fractional inhibition concentration, 
FICI = fractional inhibition concentration index, MIC = minimum inhibition concentration. 
*FICI values bold-written indicate noteworthy antibacterial synergistic interactions.   
 
 
51 
 
Findings from the evaluation of the three above-mentioned antibacterial synergistic pairs using 
the time-kill assay did not concur with those obtained from the checkerboard assay. The time-
kill curves for these combinations are presented in Figures 3.1-3.3. According to ELIOPOULOS 
AND MOELLERING (1996), noteworthy antibacterial synergy is defined by a ≥ 2 log10 decline 
in cfu/ml by the antibacterial combination when compared with the positive control (antibiotic) 
after a 24 h incubation period, ≥ 2 log10  increase in cfu/ml indicates antagonism, while a  
< 2 log10  change shows no interactions. After 24 h of interaction the log10 cfu/ml difference, 
between the antibiotic and combination treatments for these antibacterial combinations ranged 
from -0.6 to 0.3, an indication that, according to the criteria stipulated above, there were no 
significant interactions within all three combinations examined. There was a 0.2 log10 and  
0.3 log10 cfu/ml augmented killing of the MDR E. coli in combination treatments compared to 
the antibiotic (most active constituent) alone in combinations of chloramphenicol with each of 
B. speciosus MeOH bark extract and P. africana DCM leaf extract respectively, indicating 
some minor antibacterial synergistic interactions (Figures 3.1 and 3.2). In both cases, the two 
assays detected synergism, however the time-kill kinetics indicated that the interactions were 
insignificant. The checkerboard assay therefore accurately detected synergism in both 
combinations, but apparently overestimated the extent to which the two antibacterial agents 
interacted. PETERSEN et al. (2006) reported that such exaggerations are often a direct result of 
the interactions between bacteriostatic and bactericidal agents in combination therapies. 
Although the checkerboard MIC technique is one of the traditional methods used to evaluate 
antibiotic interactions, the results from this technique are not always reproducible. After 
observing major inconsistences in results obtained from the same checkerboard treatments, 
RAND et al. (1993) recommended the use of at least five replicates per each checkerboard assay 
and further suggested that more than 80% agreement among replicates is required for accurate 
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interpretations of results. Furthermore, the authors cited uneven inoculum concentrations, 
reader and pipette errors as some of the root causes of such discrepancies. 
 
Whereas the checkerboard assay, mainly assesses the bacteriostatic nature of antibacterial 
agents, the time-kill assay determines the rate and extent to which these agents kill the test 
bacterial strains (MUNDY et al., 2016). In clinical studies, these two methods are often used 
together, with the less laborious checkerboard assay being used mainly for preliminary 
screening purposes and the time-kill assay to give a more accurate estimation of the degree of 
antibacterial synergy. This is largely because the time-kill kinetic graphs gives a more vivid 
picture of changes in bacterial populations after exposure to antibiotics over time and has the 
added advantage of showing us whether the antibacterial effects are concentration-dependent 
or time-dependent (PFALLER et al., 2004). 
 
From the foregoing argument, it is evident that using the checkerboard assay alone will not 
always guarantee accurate interpretation of antibacterial synergism. Observations from the 
current study reaffirms the above statement, especially in combinations of chloramphenicol 
with P. africana leaf methanolic extract where the checkerboard assay detected noteworthy 
antibacterial synergism (FICI = 0.5) but the time-kill assay detected minor antibacterial 
antagonism within the same combinations (a -0.6 2 log10 difference between the combination 
and antibiotic treatment) (Figure 3.3). Antibacterial antagonism here implied that certain plant 
extract constituents interfered with the action of the test antibiotic (chloramphenicol) or the 
other way around. Such deleterious interactions undoubtably negate the therapeutic essence of 
antibacterial combination therapies. The current findings suggest that ethnobotanical 
evaluations of plant-based antibacterial synergistic interactions should not be done using the 
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checkerboard bioassay alone, but confirmatory time-kill assays should also be done, as 
applicable in clinical trials. 
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Figure 3.1: Time-kill curves showing the antibacterial interactions 
within combinations of chloramphenicol and Bolusanthus speciosus 
bark methanol extract against multidrug-resistant Escherichia coli. 
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Figure 3.2: Time-kill curves showing antibacterial synergistic 
effects of combinations of chloramphenicol and dichloromethane 
extracts of Prunus africana leaves against multidrug-resistant 
Escherichia coli. 
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Figure 3.3: Time-kill curves showing antibacterial interactions 
between chloramphenicol and Prunus africana methanol leaf 
extract against multidrug-resistant Escherichia coli. 
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3.4. Conclusions 
The study reveals for the first time the antigonococcal properties of S. lancea and P. africana. 
However, the safety of these plants should be further evaluated via cytotoxicity and 
genotoxicity tests. The current findings also indicate that highly efficacious and broad-
spectrum antibacterial agents could potentially be obtained from traditional medicinal plants 
such as B. speciosus. Extracts from B. speciosus, P. africana and S. lancea demonstrated 
promising activities against MDR E. coli and MDR K. pneumoniae reaffirming the potential 
use of medicinal plants as sources of novel antibacterial agents effective against MDR, Gram-
negative bacterial strains. P. caffra, a plant with a scanty ethnomedicinal history was among 
the test plant species that demonstrated broad-spectrum antibacterial activities. This plant could 
be used as a taxonomic marker for the discovery of new pharmacological compounds within 
the Proteaceae and Protea taxa. The weak antibacterial synergistic interactions detected by the 
time-kill assay in combinations of chloramphenicol with B. specious and 
P. africana reiterates the inherent potential of medicinal plant extracts in improving the activity 
of clinically inactive antibiotics. Finally, results from the current study lay special emphasises 
on the sensitivity of the time-kill assay as compared to the checkerboard assay with respect to 
antibacterial synergistic interactions within antibiotic and medicinal plant extract 
combinations. 
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CHAPTER 4: Phenolic profiles and mutagenic properties of selected plants 
 
4.1. Introduction  
Flavonoids, tannins and phenolic acids are among phytochemical secondary metabolites that 
often act as ‘chemical barriers’ to pathogenic invasions in plants (MAZID et al., 2011). 
Empirically, these bioactive phytocompounds form the principal mainstay of herbal medicine. 
Consequently, quantitative phytochemical analysis has become an integral part of 
ethnopharmacology. Different colourimetric techniques including the aluminium chloride, 
butanol-hydrochloric acid as well as the Folin and Ciocalteu (Folin C) bioassays are often used 
to determine the presence and quantity of phenolic compounds in medicinal plant extracts. 
Ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) 
has also been used widely to identify and quantify phenolic acids in medicinal plant extracts 
(KALILI AND DE VILLIERS, 2011).  
 
In addition to synthesising a wide range of pharmacologically important compounds, some 
medicinal plants also produce cytotoxins, genotoxins and mutagens as part of their natural 
defence mechanisms (ELGORASHI et al., 2003; TAYLOR et al., 2003; 
 CHUKWUJEKWU et al., 2014). Some bioactive phytocompounds, particularly sesquiterpene 
lactones, also possess potent cytotoxic and genotoxic potentials (YU et al., 2007; CHATURVEDI 
et al., 2015). It is therefore pertinent that medicinal plants be carefully screened for unwanted 
toxic effects before their continued use is encouraged. In vitro toxicological tests, such as the 
Salmonella microsome assay (Ames test) are usually favoured over animal tests due to their 
limited use of live animals, cost effectiveness, sensitivity and rapidity (ASENSIO et al., 2007).  
The current investigation sets out to identify and quantify phenolic compounds present in tested 
plant organs. The study also aimed at screening test plant extracts for mutagenic properties. 
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4.2. Materials and methods 
4.2.1. Plant collection and preparation of samples 
Plant samples were collected and prepared as described in Section 3.2.1. 
 
4.2.2. Source of chemicals 
Biotin, catechin, Folin C reagents, gallic acid, histidine and 4-nitroquinoline-N-oxide (4NQO) 
were supplied by Sigma-Aldrich Co. (Steinheim, Germany). Other chemicals utilized in this 
study included sodium carbonate and sodium nitrate (BDH Chemicals Ltd, England, United 
Kingdom); ferric ammonium sulphate (Hopkins and Williams Ltd, England, United Kingdom); 
cyanidin chloride (Carl Roth, GmbH + Co., Karlsruhe, Germany); aluminium chloride and 
sodium hydroxide (Merck KDaA, Darmstadt, Germany). 
 
4.2.3. Phenolic composition of selected plants  
4.2.3.1 Extraction for phenolics  
For each plant, 2 g of each dried-powdered material were extracted using 10 ml of aqueous 
(50%) methanol by sonification in a cold-water bath for 20 min. The extracts were then filtered 
in vacuo through Whatman No. 1 filter papers and used immediately. 
 
4.2.3.2. Assay for total phenolic content 
As described by MAKKAR et al. (2000), the Folin C assay was used to determine the total 
phenolic content in each tested plant organ. In triplicate, the reactants were mixed in succession 
as follows; 50 µl of the sample extract, 950 µl of distilled water, 500 µl of Folin C reagent  
(1 N) and 2.5 ml of 2% sodium carbonate. The blank contained a similar mixture made up of 
aqueous (50%) methanol instead of the plant sample, while varying volumes of gallic acid 
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(0.1 mg/ml) were used as a standard for generating the calibration curve. The reaction mixtures 
were then incubated at room temperature for 40 min after which absorbance was read at  
725 nm using a Cary 50 UV-visible spectrophotometer (Varian, Australia). The amount of total 
phenolics in each sample was expressed as gallic acid equivalents (GAE), derived from a 
standard curve.  
 
4.2.3.3. Assay for condensed tannins 
The concentration of condensed tannins (proanthocyanidins) in each test plant organ was 
determined using the butanol-hydrochloric acid assay (MAKKAR et al., 2000). In triplicates, 
the reaction mixtures were made up of 3 ml of butanol-hydrochloric acid reagent (95:5 v/v), 
500 µl of the plant sample and 100 µl of ferric reagent (2% ferric ammonium sulphate in 2 N 
hydrochloric acid). The blank contained a similar mixture consisting of 50% methanol instead 
of the plant extract, while varying volumes of cyanidin chloride (0.1 mg/ml) were used as a 
standard for generating the calibration curve. The mixtures were vortexed and heated in a 
boiling water bath (100 oC) for 1 h. Absorbance was then read at 550 nm using a Cary 50 UV-
visible spectrophotometer (Varian, Australia). The quantity of condensed tannins in each 
sample was expressed as cyanidin chloride equivalents (CCE), derived from a standard curve. 
 
4.2.3.4. Assay for flavonoids  
The quantity of flavonoids in each plant organ was determined using the aluminium chloride 
assay as previously described by MAKKAR et al. (2000). In triplicates, 200 µl of the plant 
sample were added to 1 ml of distilled water in a test tube, followed by 75 µl of 5% sodium 
nitrite, 75 µl of 10% aluminium chloride, 0.5 ml of 1M sodium hydroxide and 0.6 ml water. A 
similar mixture consisting of 50% methanol instead of the plant extract was used as a blank 
and catechin (0.1 mg/ ml) was used as a standard. Absorbance of the reaction mixture was then 
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read immediately (no incubation period) at 510 nm using a Cary 50 UV-visible 
spectrophotometer (Varian, Australia). The concentrations of flavonoids were expressed as 
catechin equivalents (CE), derived from a standard curve.  
 
4.2.3.5. Quantitative analysis of phenolic acids  
In triplicates, 30 mg of lyophilized plant material were transferred into a 2 ml Eppendorf tube 
and extracted with 80% methanol (30 mg/ml) and 20 µl internal standard [10-4 mol/L; solution 
of salicylic acid (3,4,5,6-2H4) and 4-hydroxybenzoic acid (2,3,5,6-
2H4)] containing  
2 mm ceria-stabilised zirconium oxide beads (Retsch GmbH & Co. KG, Haan, Germany). The 
mixture was homogenised using an Oscillation ball mill for 3 min at a frequency of  
27 Hz/s and an ultrasonicator for 15 min, then centrifuged ( 26 000 g) at 4 oC for 10 min. The 
resultant supernatants were transferred into Eppendorf tubes and re-extracted as previously 
described above. Both extracts were combined and dried in an oil evaporator for 6-8 h.  
 
The supernatants were filtered through 0.45 mm nylon membrane filters (Alltech, Breda, 
Netherlands) and analysed using the UHPLCTM system (Waters, Milford MA, USA), linked to 
a Micromass Quattro API triple quadrupole mass spectrometer (Waters, Milford MA, USA) 
which was equipped with a Z- spray electron spray ionisation (ESI) source operating in the 
negative mode as previously described by GRUZ et al. (2008). The UHPLCTM was also 
connected to a PDA 2996 photo diode array detector (Water, Milford, MA, USA). All phenolic 
acids were identified and quantified using authentic standards. 
 
4.2.3.6. Data analysis 
The quantification of all phenolic compounds was done in triplicate and the results presented 
as mean ± standard error. Mean values were compared using one-way analysis of variance 
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(ANOVA) and where statistical significance (p ≤ 0.05) existed, these values were further 
separated using the Duncan’s multiple range test. Bio-statistical analysis were done using the 
SPSS version 24.0 for Windows (IBM SPSS Inc., Chicago, IL) and all graphs were done using 
Graph Pad Prism version 5.0 for Windows (Graphpad Software Inc., San Diego, CA). 
 
4.2.4. Mutagenic properties of selected medicinal plant 
4.2.4.1 Ames test 
The mutagenic properties of medicinal plant extracts that demonstrated noteworthy 
antibacterial activities (Tables 3.1 and 3.2) were evaluated using the Ames Salmonella/ 
microsome assay involving two Salmonella typhimurium tester strains, TA98 and TA102, in 
the absence of S9 metabolic activation (MARON AND AMES, 1983; ELGORASHI et al., 2003). 
One hundred microliters of each stock tester strain were incubated in 10 ml of Oxoid nutrient 
broth No. 2 for 16 h at 37 oC to achieve a cell density ≈ 1 x 109 cfu/ml. In triplicate, 100 µl of 
3 dilutions (50, 500 and 5 000 µg/ml) of each plant extract were mixed with 500 µl of phosphate 
buffer (0.1 mM, pH 7.4), followed by 100 µl of the tester bacterial strain and 2 ml of sterile 
melted top agar supplemented with 0.5 mM of biotin and histidine (0.5 mM). The mixture was 
vortexed then transferred into minimal agar plates and allowed to solidify for 2-3 min. One 
hundred microliters of 50% methanol served as the solvent control, while 2 µg/ plate of 4NQO 
were used as the positive control. The number of viable colonies in each plate was determined 
after incubation at 37 oC for 48 h. The assay was conducted twice and results presented as  
mean ± standard error number of reverted colonies per plate. Plant samples that induced a 2-
fold increase in the number of His+ revertants compared to the negative control were considered 
to be mutagenic. Additionally, samples that exhibited a dose-dependent increase in the number 
of His+ revertants were classified as mutagenic (CARIELLO AND PIEGORSCH, 1996). 
  
 
 
63 
 
4.3. Results and discussion 
4.3.1. Phenolic compositions of selected medicinal plants 
Natural phenolic compounds play a significant role in the prevention and management of 
several infectious and non-infectious diseases (SHAHIDI AND NACZK, 1995; SHAHIDI, 2004). 
This perhaps explains why a considerable number of traditional medicinal plants contain high 
levels of phenolic compounds (POLYA, 2003). In the present study, different quantitative 
phytochemical analysis techniques were employed to determine the quantity of phenolic 
compounds present in each tested plant organ.  
 
The total phenolic content in the tested plant organs ranged from 5.57-62.73 mg GAE/g DW 
(Figure 4.1). The highest concentrations of total phenolics, condensed tannins (Figures 4.1 and 
4.2), gallic and catechin acids (Table 4.1) were detected in S. lancea leaves. It may, therefore, 
be inferred that the extended-spectrum antibacterial properties exhibited by 
S. lancea leaves (Chapter 3, Tables 3.1 and 3.2) was due to the presence of highly concentrated 
phenolic compounds in these leaves. Other medicinal plants that contained relatively higher 
levels of total phenolics and also displayed broad-spectrum antibacterial properties were  
P. africana leaves and P. caffra twigs. The leaves of P. africana contained more condensed 
tannins (15.5 mg CCE/g DW) than flavonoids (13.5 mg CE/g DW), while 
P. caffra twigs contained slightly higher amounts of flavonoids (26.7 mg CE/g DW) than 
condensed tannins (22.1 mg CCE/g DW) as shown in Figures 4.2 and 4.3. Both tested plant 
organs also contained varying quantities of both hydroxybenzoic and hydroxycinnamic acids 
(Tables 4.1 and 4.2). The antibacterial properties of phenolic compounds are substantially 
attributable to the numerous hydroxyl and other functional groups they possess which often 
binds to the intra- and extracellular components of bacterial cells  
(COWAN, 1999; BORGES et al., 2013). These lethal interactions often cause irreversible 
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damage to bacterial cell walls as well as membranes leading to excessive leakages of  
cyto- and nucleoplasm (TAYLOR et al., 2005; LOU et al., 2012). 
 
It is, however, important to note that not all tested plant organs containing higher levels of total 
phenolics displayed noteworthy antibacterial properties. P. caffra leaves contained the second 
highest concentration of total phenolics (Figure 4.1) and the overall highest concentrations of 
flavonoids (Figure 4.3), caffeic, p-coumaric, p-hydroxybenzoic and p-protocatechuic acids 
(Tables 4.1 and 4.2) but was only active against 38 % of the bacterial strains evaluated in 
Chapter 3 (Tables 3.1 and 3.2). Similarly, E. capensis leaves, P. africana twigs, as well as the 
bark and flowers of P. caffra contained total phenolics in the range of  
27.9-52.7 mg GAE/g DW and varying amounts of phenolic acids, but demonstrated promising 
antibacterial activities (MIC<1 mg/ml) against at most three test bacterial strains (none of 
which were Gram-negative).  
 
Generally, B. speciosus bark, C. myriocarpus fruits as well as S. panduriforme fruits, leaves, 
stems and roots contained very low quantities of phenolic compounds. Table 4.1 shows that 
catechin acid was not detected in all of the test plant organs mentioned above. However, despite 
containing very low concentrations of phenolics, the bark of B. speciosus displayed broad-
spectrum and potent antibacterial activities (Table 3.1-3.2). These findings generally concurred 
with those of MULAUDZI et al. (2011). Tables 4.1 and 4.2 show that the bark of 
B. speciosus also contained some phenolic acids known to have antibacterial properties such 
as caffeic, ferulic, gallic, p-coumaric and sinapic acids (BARBER et al., 2000; ENGELS et al., 
2012; BORGES et al., 2013). These phenolic acids probably synergise the antibacterial 
flavonoids found in this medicinal plant such as Bolusanthin II, Bolusanthin III and 
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Bolusanthin IV (BOJASE et al., 2002; ERASTO et al., 2004). All the antibacterial compounds 
produced by this plant should, however, be isolated and identified to substantiate this inference.  
 
The overall weak antibacterial properties displayed by C. myriocarpus and S. panduriforme 
(Table 3.1-3.2) could be attributed to lower concentrations of phenolics in extracts obtained 
from these plants (Figures 4.1-4.3, Tables 4.1-4.2). It should be noted that nearly all phenolic 
compounds screened in the present study were present in both medicinal plants  
(Figures 4.1-4.3 and Tables 4.1-4.2). However, since these putative antibacterial compounds 
occurred in very low quantities, they were perhaps over-diluted to effect notable antibacterial 
activities. Chances are also that their antibacterial activities were easily antagonised or 
interfered with by other more concentrated, structurally similar chemical constituents within 
the medicinal plant extracts. The latter applies especially where the antibacterial mechanism 
was through competitive inhibition of bacterial enzymes.  
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Figure 4.1: Total phenolic content (GAE: Gallic acid equivalents) in 50% methanol extracts 
of seven South African traditional medicinal plants. Bar represents mean ± standard error, 
n = 3. Plant organs with different letter(s) are significantly (p ≤ 0.05) different as separated by 
Duncan’s Multiple Range Test. Bs = Bolusanthus speciosus, Cm = Cucumis myriocarpus, 
Ec = Ekebergia capensis, Pc = Protea caffra, Pa = Prunus africana, Sl = Searsia lancea, 
Sp = Solanum panduriforme. 
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Figure 4.2: Quantity of condensed tannins (CCE: Cyanide chloride equivalents) in 
50% methanol extracts of seven South African traditional medicinal plants. Bar 
represents mean ± standard error, n = 3. Plant organs with different letter(s) are 
significantly (p ≤ 0.05) different as separated by Duncan’s Multiple Range Test. 
Bs = Bolusanthus speciosus, Cm = Cucumis myriocarpus, Ec = Ekebergia capensis, 
Pc = Protea caffra, Pa = Prunus africana, Sl = Searsia lancea, 
Sp = Solanum panduriforme. 
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Figure 4.3: Quantity of total flavonoids (CE: Catechin equivalents) in 50% methanol extracts 
of seven South African traditional medicinal plants. Bar represents mean ± standard error, 
n = 3. Plant organs with different letter(s) are significantly (p ≤ 0.05) different as separated by 
Duncan’s Multiple Range Test. Bs = Bolusanthus speciosus, Cm = Cucumis myriocarpus, 
Ec = Ekebergia capensis, Pc = Protea caffra, Pa = Prunus africana, Sl = Searsia lancea, 
Sp = Solanum panduriforme. 
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Table 4.1: Quantity (µg/g DW) of hydroxybenzoic acids in 80% methanol plant extracts. Values represent mean ± standard error, n=3. Plant 
organs with different letter(s) are significantly (p ≤ 0.05) different as separated by Duncan’s Multiple Range Test. <LOD = below level of 
detection. 
Hydroxybenzoic acids 
Plant species  
 
Plant 
part 
Catechin 
Acid 
Gallic  
Acid 
p-Hydroxybenzoic 
acid 
p-Protocatechuic 
acid 
Salicylic 
acid 
Syringic 
acid 
Vanillic 
acid 
Bolusanthus speciosus Bark < LOD 0.14d 3.02± 0.13e 3.82 ±0.07i 0.37 ±0.11k 1.63± 0.04fg 6.55 ±0.19e 
Cucumis myriocarpus Fruits < LOD 0.23d 22.88 ±0.27d 0.9 ±0.02i 0.95 ±0.14j 0.48± 0.03h 13.5 ±0.15cd 
Ekebergia capensis Leaves 14.45± 033c 2.47 ±0.16b 6.89 ±0.25e 20.56 ±0.71gh 6.57± 0.06e 4.49 ±0.31b 0.98± 0.03f 
Protea caffra Bark 6.83 ±1.4d 0.3±0.3d 1.95 ±0.1e 88.1± 4.4c 0.1 k 2.4 ±0.4cd 4.7 ±0.2e 
 Leaves 17.98 ±0.51b 1.50±0.03c 374.55 ±9.14a 184.35± 4.44a 5.07 ±0.08g 1.22± 0.02g 23.35± 0.13b 
 Seeds < LOD 0.69 ±0.23d 23.74 ±0.37d 44.22 ±1.32e 1.55± 0.04 hi 0.67± 0.03h 4.8±9 0.2e 
 Twigs 13.02 ±2.03c 0.42± 0.02d 4.94 ±0.36e 17.65± 0.76h 1.85± 0.03h 1.28± 0.3g 6.66 ±0.09e 
 Flowers 4.08 ±1.3f 1.63 ±0.04c 156.87± 5.03b 50.35 ±1.57d 7.73± 0.36d 1.58 ±0.07fg 10.86 ± 0.7d 
Prunus africana Twigs 6.28 ±0.48d 0.13 ± 0.01de 7.89 ±0.24e 31.78 ± 0.83e 18.81 ± 0.33a 1.53 ±0.05g 14.83 ±0.2c 
 Leaves 4.72 ±0.06e 1.55 ±0.03c 8.86± 0.24e 23.52 ±0.77g 11.38± 0.25b 0.29 ±0.01h 4.44± 0.07e 
Searsia lancea Leaves 66.78 ±1.29a 29.5± 0.74a 47.83± 0.76c 123.24± 1.33b 9.92 ±0.39c 1.36 ±0.02g 4.46 ±0.08e 
Solanum panduriforme  Fruits < LOD 2.59± 0.12b 4.91± 0.05e 16.83± 0.15h 1.27± 0.02ji 2.04 ±0.03de 5.97± 0.21e 
 Leaves < LOD 1.35 0.07c 29.27 0.71d 21.88 0.74gh 5.22 ±0.13g 8.09 ±0.36a 82.89 3.4a 
 Stems < LOD 0.29± 0.02d 9.64 ±0.36e 5.56 ±0.03i 7.35± 0.09d 2.69 ±0.11c 21.61± 0.92b 
 Roots < LOD 0.061± 0.01d 2.76 ±0.04e 1.37± 0.03i 5.88± 0.1f 1.96 ±0.11ef 13.9± 0.19c 
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Table 4.2: Quantity (µg/g DW) of hydroxycinnamic acids in 80% methanol plant extracts. Values represent mean ± standard error, n=3.  
Plant organs with different letter(s) are significantly (p ≤ 0.05) different as separated by Duncan’s Multiple Range Test. <LOD = below 
level of detection. 
Plant species  Plant 
part 
Hydroxycinnamic acids 
  Caffeic acid Chlorogenic acid p-Coumaric acid Ferulic acid Sinapic acid 
Bolusanthus speciosus Bark 0.3±0.01i < LOD 5.27±0.09e 5.74±0.12g 1.44±0.04b 
Cucumis myriocarpus Fruits 0.16±0.01i 166.47±5.56c 10.71±0.12c 4.8±0.04h 1.47±0.03b 
Ekebergia capensis  Leaves 63.12±2.01b < LOD 9.9±0.37cd 11.51±0.3c 0.75±0.03c-e 
Protea caffra Bark 5.69±0.22h 0.56±0.03j 1.69±0.06g 14.12±0.39b 0.2d-f  
 Leaves 266.37±1.46a 11.67±0.28hi 21.22±0.54a 2.68±0.18i 0.08 f 
 Seeds 29.09±0.77d 3.34±0.16j 10.03±0.4c 4.89±0.2c 0.09±0.01f 
 Twigs 9.36±0.39g 29.91±1.21g 5.3±0.26e 5.68±0.26g 0.23±0.13d-f 
 Flowers 39.36±1.39c 4.82±0.2j 10.77±0.62c 6.92±0.13f 0.24±0.03d-f 
Prunus africana  Twigs 1.17±0.53i 224.5±4.54b 1.89±0.08g 8.91±0.25c 1.39±0.01b 
 Leaves 14.02±0.41f < LOD 16.42±0.31b 10.04±0.36d 0.79±0.04cd 
Searsia lancea  Leaves 18.12±0.32e 78.21±1.38e 9.14±0.07d 7.04±0.07f 0.13 ef 
Solanum panduriforme  Fruits 2.59±0.12b 347.77±4.5a 5.08±0.07e 15.25±0.16a 11.33±0.74a 
 Leaves 6.02±0.19h 18.76±0.5h 3.51±0.12f 8.29±0.21c 1.13±0.03bc 
 Stems 5.84±0.19h 44.98±1.24f 1.35±0.06gh 5.4±0.16gh 0.78±0.04cd 
 Roots 9.86±0.21g 100.4±3.17d 0.67 h 6.52±0.15f 0.59±0.03c-f 
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4.3.2. Mutagenic properties of selected medicinal plant species 
The exorbitant cost of pharmaceutical drugs has seen a considerable number of people turning 
to complementary and/or alternative herbal medicine. However, since some medicinal plant 
species are inherently toxic (TAYLOR et al., 2003), the safety of traditional herbal remedies 
remains a serious cause of concern. The absence of legislative guidelines with respect to the 
preparation, prescription and administration of herbal medicines in folk medicine 
(FENNELL et al., 2004) exposes patients to risks of medicinal plant poisoning. Often, cases of 
phyto-poisoning are poorly documented and as such, the actual mortality rates due to medicinal 
plants remains largely unknown (MACE et al., 1998). It is therefore imperative that all 
medicinal plants be thoroughly screened for potential toxic effects to ensure their safe 
application in both western and folk medicine.  
 
Due to limited available resources, only plant extracts that demonstrated noteworthy 
antibacterial activities (Chapter 3) were screened in the present study for mutagenic effects. 
The samples were not screened for any indirect mutagenic potentials because the exogenous 
metabolic system (S9 mix) was unavailable. Table 4.3 shows that none of the test plant extracts 
demonstrated a concentration-dependent increase in the number of His+ revertants. The average 
TA98 revertants for all plant extract dilutions ranged from 6.4-60.7 while the TA102 revertants 
ranged from 172.5-426.7. The corresponding average number of revertants in the negative 
control (4NQO) were 191.9 and 296.7, respectively. Based on these findings, all tested plant 
extracts were non-mutagenic against the Salmonella tester strains TA98 and TA102 
(CARIELLO AND PIEGORSCH, 1996). However, IRUNGU et al. (2014) reported on the cytotoxic 
properties of E. capensis, while TAYLOR et al. (2003) demonstrated the genotoxic potentials 
of P. africana, suggesting that these two medicinal plants were not entirely safe to administer 
to patients. NDHLALA et al. (2010) also observed that while some medicinal plants 
 
 
72 
 
demonstrated non-mutagenic effects against TA98, they were found to be cytotoxic and 
capable of inducing indirect mutagenesis. It should also be kept in mind that besides 
mutagenesis, carcinogens can also induce cancerous growth in animals through altering 
intracellular signals and gene expressions (VERSCHAEVE et al., 2004). The full toxic potentials 
of medicinal plants can, therefore, only be revealed by subjecting samples to rigorous and 
diverse toxicological tests. 
 
Based on accessed literature, none of the plant species within the Bolusanthus and Protea 
genera have been reported to have potential toxic effects on humans. The current literature, 
however, indicates that some plant species within the Cucumis, Solanum and  
Searsia (syn. Rhus) genera have potential toxic effects on humans (NEUWINGER, 1996; 
TANNER, 2000; KAYOKA et al., 2016). Medicinal plants within these genera, including those 
evaluated in the present study, should be used with extreme caution, especially in poorly-
regulated folk medicine. Although the current data indicates that members of these genera were 
non-mutagenic, thorough in vivo studies are needed before these medicinal plants are declared 
safe for human consumptions. 
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Table 4.3: Number of His+ revertants in Salmonella typhimurium strains TA98 and TA102 produced by different medicinal plant extracts (without 
S9 metabolic activation). 
 
 
  Number of His+ revertants/plate  
(mg/ml) 
Plant species Plant extract TA98 TA102 
  5 0.5 0.05 5 0.5 0.05 
Bolusanthus speciosus Bark DCM 16.7 ±7.5 12.7±2.1 12.3±1.2 426.7±33.1 233.3± 15.9 245.3±18.0 
 Bark MeOH 19.3±4.5 19.0±6.6 22.3±3.2 330.7±32.2 422.7±17.2 317.3±35.2 
Cucumis myriocarpus Fruit MeOH 7.3±3.6 10.1±1.5 12.4±1.6 178.6±12.5 247.8±19.3 198.2±32 
Ekebergia capensis Leaf DCM 10.3±1.3 15.6±7.3 11.4±3.4 186±33.2 291.3±15.9 315±17.9 
Protea caffra Bark MeOH 9.7±2.3 8.3±3.2 10.7±1.5 248.0±20.1 274.7±11.7 177.3±15.5 
 Bark PE 6.4±2.1 9.8±4.1 15.8±6.1 213.5±15.9 172.5±26.2 245.6±21.1 
 Flower PE 13.6±5.2 8.8±2.6 12.6±3.2 301±12.1 245.3±22.5 207±12.8 
 Seed DCM 8.0±4.6 7.0±3.6 8.7±4.7 269.3±22.0 253.3±28.3 224.0±5.6 
 Seed MeOH 9.7±2.1 10.0±2.6 10.7±2.1 225.3±21.1 278.7±8.5 260.0±2.6 
 Seed PE 8.7±3.2 11.6±1.9 21.9±7.6 269±33.6 276±18.2 208±25.6 
 Twig MeOH 22.0±6.2 29.0 ±8.2 17.3±6.7 192.0±6.2 320.0±22.5 293.3±27.4 
 Leaf MeOH 16.7±1.5 15.7±11.0 27.0±11.4 392.0±30.2 290.7±22.0 416.0±43.9 
 Leaf PE 7.2±2.3 22.8±7.6 19.5±4.9 233.6±16.5 246±17.7 317.6±14.7 
Prunus africana Leaf DCM 19.3±6.3 23.3±7.2 11.4±2.3 189±23.5 314.1±25.3 236.6±21.3 
 Leaf MeOH 18.6±3.2 28.7±6.3 21.6±6.1 223.2±21.6 315.2±20.2 205±20.1 
 Leaf PE 24.6±3.1 22.4±8.6 32.7±9.9 338.6±10.6 275.3±7.1 187±12.2 
 Twig MeOH 25.3±8.4 21.6±6.1 22.5±7.3 220.6±31.5 198.6±8.1 312.5±29.4 
 Twig DCM 13.5±4.2 18±4.5 19.2±9.1 195±12.3 183.1±13.4 205.9±23.6 
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Table 4.3: Continued. 
 
 
 
 
 
 
 
 
 
 
 
 
  Number of His+ revertants/plate  
(mg/ml) 
Plant species Plant extract TA98 TA102 
  5 0.5 0.05 5 0.5 0.05 
Searsia lancea Leaf DCM 17.3±8.1 23.0±12.2 11.3±3.2 340.9±41.0 234.7±22.0 325.3±10.1 
 Leaf MeOH 16.7±2.3 60.7±10.1 38.3±21.0 248.0±16.6 201.3±11.2 181.3±11.7 
 Leaf PE 17.4±1.9 45.9±12.8 35.3±12.5 312±21.3 198.3±32.9 174.2±10.2 
Solanum panduriforme Root DCM 22.4±4.5 11.4±1.4 12.3±5.3 264.3±22.6 175±10.6 245.7±33.5 
Water (-ve control)   19.1±8.4   145.2±17  
4-NQO (+ve control)   191.9±17.3   296.7±20.6  
The data presented are the mean ± standard error of six plates from two separate experiments each performed in triplicate. 
DCM = Dichloromethane, MeOH = Methanol, PE = Petroleum ether, 4-NQO = 4-nitroquinoline-oxide, -ve= negative, 
 + ve = positive control. 
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4.4 Conclusions 
Phenolic compounds contribute to the therapeutic properties of most traditional medicinal plant 
species. The current study revealed variations in the total phenolic content, flavonoid, 
condensed tannin and phenolic acid concentrations in the medicinal plant organs evaluated. 
The higher concentrations of phenolic compounds detected in S. lancea leaves, P. africana 
leaves as well as the twigs of P. caffra could perhaps justify the broad-spectrum antibacterial 
activities displayed by extracts from these plant organs as elucidated in the previous Chapter. 
Interestingly, the bark of B. speciosus contained very low quantities of nearly all phenolic 
compounds evaluated, yet demonstrated broad-spectrum and the overall best antibacterial 
activity. Overall, no obvious correlations between antibacterial efficacy and the quantity of 
phenolics present in the tested plant organs could be established. Apparently, antibacterial 
activity and spectrum were subject to the type, quality and quantity of phenolic compounds 
present in each medicinal plant organ. Plant organs that did not demonstrated good antibacterial 
properties (MIC > 1 mg/ml) but contained higher levels of phenolic compounds such as the 
leaves, bark and flowers of P. caffra and the leaves of E. capensis should be screened for other 
pharmacological activities such as antioxidants, antiviral, antifungal, anti-inflammatory, 
antimutagenic and anticarcinogenic properties. It was encouraging to note that none of the test 
plant extracts induced frameshift or point mutations. However, rigorous in vitro and in vivo 
toxicological tests are needed to ascertain the safety of all seven medicinal plants assessed in 
the current investigation. 
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CHAPTER 5: Identification of putative antibacterial compounds in Searsia 
lancea and Protea caffra 
 
5.1. Introduction  
The multi-stage process of pharmaceutical drug discovery and development often starts with 
the identification of the principal bioactive molecules from natural sources such as plants and 
microbes. In this context, ethnobotany and ethnopharmacology play a crucial role in guiding 
scientists into discovering novel therapeutic molecules from plants. 
 
The isolation of bioactive phytocompounds dates back to the early 1800’s when two French 
scientists, Caventou and Pelletier, isolated an anti-malarial compound (quinine) from a 
medicinal plant (Cinchona officinalis) commonly used in the Amazon region to treat fevers at 
the time (GURIB-FAKIM, 2006). Over the years, ethnobotany and ethnopharmacology have 
become prominent scientific disciplines focusing on, among other things, validating the 
traditional use of medicinal plants. Using data generated from ethnobotanical inquiries and 
ethnopharmacological studies, chemists are able to find novel sources and groups of 
pharmacologically important phyto-compounds (TAYLOR et al., 2005; MURATA et al., 2008; 
BORGES et al., 2013).  
 
Appropriate extraction and isolation techniques are key requisites for successful isolation of 
biologically active compounds from natural sources (ATANASOV et al., 2015). The bioactivity-
guided fractionation technique has been instrumental in the isolation of active phyto-
compounds for decades (BRUSOTTI et al., 2014). This technique employs the use of bioassays 
and column chromatography to isolate compounds in a given sample according to their 
biological activities and polarity (PRABHAKAR et al., 2006). Other chromatographic techniques 
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such as Thin Layer Chromatography (TLC) are often used to further purify the fractions 
obtained from column chromatography (ATANASOV et al., 2015). Once the putative 
pharmacological compounds have been successfully isolated, the next step is their 
characterization and identification. This is often achieved through 1- and 2-dimensional 
Nuclear Magnetic Resonance (NMR), Infra-Red (IR), Mass Spectroscopy (MS) and X-ray data 
analysis (GURIB-FAKIM, 2006). Subsequently, in vitro and in vivo pharmacological tests are 
often necessary to determine the efficacy and toxicity of the isolated compounds. 
 
S. lancea and P. caffra are used in African traditional medicine to treat a wide range of both 
infectious and non-infectious diseases (HUTCHINGS et al., 1996; COETZEE AND LITTLEJOHN, 
2000; SEMENYA et al., 2013a). Empirical evidence suggests that the leaves of S. lancea and  
P. caffra twigs have potent inhibitory properties against a wide range of bacterial strains, 
including Gram-negative multiple drug-resistant (MDR) mutants (Chapter 3). In addition, the 
data presented in Chapter 4 (Figures 4.1-4.3 and Tables 4.1-4.2) indicates that both plants 
contain a wide range of phenolic compounds which possess antibacterial properties. 
Furthermore, the Ames test results indicated that these two medicinal plants did not have 
potential mutagenic effects (Table 4.3, Chapter 4). Over and above this, little is currently 
known about the antibacterial compounds in both plants. On this premise, the present study 
was aimed at identifying the antibacterial compounds from the leaves of  
S. lancea and twigs of P. caffra. 
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5.2. Material and methods 
5.2.1. Identification of putative antibacterial compounds in Searsia lancea  
5.2.1.1. General 
Open column chromatography was carried out using Sephadex LH-20 (Sigma-Aldrich). TLC 
was performed at room temperature using pre-coated silica glass plates (Merck glass plates, 
20x20 cm, silica gel F254, 0.25 mm thickness). Detection of spots on chromatograms was done 
under ultra-violet light (254 and 366 nm). Proton Nuclear Magnetic Resonance (1HNMR) 
spectroscopy was performed at the School of Chemical and Physical Sciences, University of 
KwaZulu-Natal, Pietermaritzburg, using a Bruker AV400 spectrometer (400 and 500 MHz). A 
Perkin-Elmer 241 polarimeter installed with a λ589 sodium lamp was used to determine the 
optical rotations. 
 
5.2.1.2. Plant collection and extraction 
The leaves were collected and samples prepared as described in Section 3.2.1. Antibacterial 
compounds were isolated from the leaves of S. lancea as previously described by 
NAIR et al. (2013), with some modifications. The dry powdered leaf sample of S. lancea  
(850 g) was mixed with one litre of 70% aqueous methanol (MeOH) and stirred for 24 h at 
room temperature. The resultant extract was filtered in vacuo, though a Büchner funnel and 
Whatman No. 1 filter paper. The extraction and filtration were subsequently done thrice, after 
which the combined extracts were concentrated using a rotary evaporator (Heldolph vv 2000, 
Germany) at 30 ºC. 
 
 
 
79 
 
5.2.1.3. Liquid-liquid fractionation of the crude plant extract 
The concentrated 70% MeOH leaf extract was sequentially extracted with n-hexane 
(3x250 ml), dichloromethane (3x250 ml) and ethyl acetate (3x400ml). The resultant fractions 
were separately concentrated to dryness in vacuo to give four solvent fractions: hexane (Hex), 
dichloromethane (DCM), ethyl acetate (EtOAc) and MeOH. All four fractions were screened 
for antibacterial activity against a panel of seven bacterial strains (E. faecalis, MDR E. coli,  
K. pneumoniae, MDR K. pneumoniae, S. aureus, penicillin-resistant S. aureus and  
N. gonorrhoeae) as described in Section 3.2.5.2.  
 
5.2.1.4. Column chromatography 
The fraction that gave the best antibacterial activity in Section 5.2.1.3. was further purified on 
a Sephadex LH-20 column using a DCM/EtOAc (1:0-0:1) solvent system followed by an 
increasing gradient of EtOAc up to 100% and MeOH up to 40%. The resultant fractions were 
spotted on TLC plates and developed in DCM/EtOAc (4:1). Fractions with similar chemical 
profiles were combined and subjected to antibacterial susceptibility tests as described in 
Section 3.2.5.2.  
 
5.2.1.5. Preparative Thin Layer Chromatography 
The fraction that gave the best antibacterial activity in Section 5.2.1.4. was further purified 
through preparative TLC. The fraction (7.9 mg) was loaded onto a TLC silica glass plate and 
developed using a DCM/EtOAc (1:1) solvent system. Isolated pure compounds were screened 
for antibacterial activities as described in Section 3.2.5.2. The isolation scheme used in the 
present study is summarised in Figure 5.1. 
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                        Dried leaf sample (850 g) 
                                                Extraction 
             70 % aqueous methanol leaf extract (123 g) 
                                                                      
                                                 
                                     Fractions 
 Hex            DCM            EtOAc            MeOH 
 
                                                                   
                                    Fractions 
      1          2          3          4         5           6           7          8 
(7.9 mg)  
        
       
Compound 1       Compound 2                 Sub-fraction 5 
        
         
 
      NMR spectroscopy                                        GC-MS analysis 
Figure 5.1: Flow diagram illustrating the bio-guided isolation of two antibacterial compounds 
from aqueous (70%) methanol leaf extracts of Searsia lancea.  
DCM = Dichloromethane, EtOAc = Ethyl acetate, GC-MS = Gas Chromatograph-Mass 
Spectroscopy, Hex = Hexane, MeOH = Methanol, NMR = Nuclear magnetic resonance,  
TLC = Thin layer chromatography. 
 
 Liquid-liquid fractionation 
Preparative TLC 
 Column chromatography 
(7.87 g) 
(0.7 mg)  (1.2 mg) 
Bioactivity testing 
 
Bioactivity testing 
 
Bioactivity testing 
 (0.5 mg) 
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5.2.1.6. Gas Chromatography-Mass Spectroscopy (GC-MS)  
GC-MS analysis was carried out at the School of Chemical and Physical Sciences, University 
of KwaZulu-Natal, Pietermaritzburg using a Shimadzu QP-2010 SE Gas Chromatography 
coupled with (an Agilent) 5973 Mass Selective detector and driven by Agilent Chemstation 
software. A Zebron ZB-5MSplus capillary column (30 m x 0.25 mm internal diameter, 
0.25 µm film thickness) was used. The carrier gas was ultra-pure helium at a flow rate of 
1.0 ml/min and a linear velocity of 37 cm/s. Three microlitres of the sample were injected into 
the column with the injector temperature set at 250 oC. The initial oven temperature was at  
60 oC which was programmed to increase to 280 oC at the rate of 10 oC per min with a hold 
time of 3 min at each increment. The mass spectrometer was operated in the electron ionization 
mode at 70 eV and electron multiplier voltage at 1859 V. Other MS operating parameters were 
as follows: ion source temperature 230 oC, quadrupole temperature 150 oC, solvent delay 4 min 
and scan range 50-700 amu. 
 
The compounds were identified by direct comparison of the mass spectrum of the analyte at a 
particular retention time to that of reference standards found in the National Institute of 
Standards and Technology (NIST) library. The area percentage of each component was 
calculated by comparing its average peak area to the total areas obtained.  
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5.2.2. Identification of putative antibacterial compounds in Protea caffra  
5.2.2.1. Plant collection and extraction 
P. caffra twigs were collected and samples prepared as described in Section 3.2.1. The dry 
powdered samples were mixed with methanol (10 ml/g) and stirred in a rotary shaker (Edmund 
Bühler, Tübingen, German) for 12 h at 150 rpm at room temperature, after which they were 
sonicated for 1 h on ice (Julabo GMBH, Germany). The resultant extract was filtered using 
Whatman No. 1 filter paper under vacuum and later concentrated using a rotary evaporator 
(Heldolph vv 2000, Germany) at 35 oC.  
 
5.2.2.2. Liquid-to-liquid fractionation and GC-MS analysis 
The concentrated 70% methanol extract was sequentially extracted with acetone (3x100 ml), 
cold ethyl acetate (10 oC, 3x50 ml) and hot ethyl acetate (50 oC, 3x50 ml). The resultant 
fractions were separately concentrated to dryness in vacuo to give four solvent fractions: 
acetone, cold ethyl acetate, hot ethyl acetate and methanol. The four fractions were screened 
for antibacterial activity against a panel of eight bacterial strains (E. faecalis, E. coli,  
MDR E. coli, K. pneumoniae, MDR K. pneumoniae, S. aureus, penicillin-resistant S. aureus 
and N.  gonorrhoeae) as described in Section 3.2.5.2. GC-MS analysis of the four fractions 
was carried out as described in Section 5.2.1.6.  
 
5.3. Results and discussion 
5.3.1. Identification of putative antibacterial compounds in Searsia lancea 
A resultant yield of 123 g was obtained from the extraction of S. lancea leaves with 70% 
MeOH. Liquid-liquid fractionation of that extract resulted in four fractions (DCM, Hex, EtOAc 
and 70% aqueous MeOH), whose antibacterial activities (MIC) are presented in 
Table 5.1. It should be noted that the bacterial strains used were selected based on the 
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antibacterial activities of S. lancea organic solvent extracts observed in Chapter 3 (Tables 3.1 
and 3.2). The fractions did not exhibit noteworthy antibacterial activities against 
K. pneumoniae and all three drug-resistant bacterial strains evaluated (MIC’s > 2.5 mg/ml), the 
70% MeOH fraction was the only one active against N. gonorrhoeae (MIC = 0.6 mg/ml).  
E. faecalis and S. aureus were susceptible to nearly all fractions (four) evaluated. The most 
potent fraction with regards to antibacterial activity was, however, the one eluted with EtOAc 
which achieved an MIC value of 0.078 mg/ml against both E. faecalis and S. aureus.  
 
Gravity-assisted column chromatography of the EtOAc fraction (7.87 g) resulted in 325 
fractions which, based on their TLC profiles, were combined to form eight sub-fractions. As 
indicated in Table 5.1, it was only the EtOAc fraction 1 that displayed noteworthy antibacterial 
activities against E. faecalis and S. aureus (MIC values of 0.031 and  
0.061 mg/ml, respectively). Further purification of the EtOAc fraction 1 by preparative TLC 
led to the isolation of an oily compound (compound 1) and a white powdered compound 
(compound 2).  
 
According to GIBBONS (2004), a natural compound with antibacterial activities (MIC) of 
0.064-0.1 mg/ml has clinical relevance. Using this benchmark, the two isolated compounds 
exhibited good antibacterial activities against E. faecalis and S. aureus as recorded in Table 
5.1. Interestingly, the MIC value of compound 1 (0.016 mg/ml) against E. faecalis and 
S. aureus was almost 3 and 4 times more than that the positive control (neomycin) yielded 
against the same bacterial strains, respectively. Additionally, the clinical MIC breakpoints of 
some antibiotics (amoxicillin and ampicillin) used to manage E. faecalis infections was about 
half that of compound 1 (EUCAST, 2018), reiterating that this phytocompound was indeed 
highly efficacious. GUNDIDZA et al. (2008) demonstrated that the essential oils from the leaves 
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of S. lancea had potent antimicrobial and antioxidant activities. The authors speculated that the 
possible antimicrobial compounds within these essential oils were α-pinene, benzene,  
δ-3-carene, isopropyl toluene and trans-caryophyllene. The possibility that compound 1, which 
was isolated in an oily state in the present study, could be one of the afore-mentioned 
compounds cannot be completely ruled out. However, if both compound 1 and 2 are unknown, 
then their chemistry and antibacterial mechanism(s) could possibly inspire scientists to 
developing new types/classes of antibiotics. These compounds could for instance, be used as 
the primary active ingredients in antibiotics or used to make semi-synthetic and/or synthetic 
antibacterial agents. 
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Table 5.1: Minimum inhibitory concentration values (MIC, mg/ml) of fractions and compounds obtained from the bioactivity-guided isolation of 
antibacterial compounds from the leaves of Searsia lancea. 
DCM = Dichloromethane, EtOAc = Ethyl Acetate, Hex = Hexane, MeOH = Methanol, - = Not tested, a = positive control, Ec D = Multidrug-
resistant Escherichia coli, Ef = Enterococcus faecalis, Kp = Klebsiella pneumoniae, Kp D = Multidrug-resistant Klebsiella pneumoniae, 
Sa = Staphylococcus aureus, Sa D = penicillin resistant Staphylococcus aureus, Ng = Neisseria gonorrhoeae.* Values in bold are considered 
noteworthy.   
 MIC (mg/ml) 
Compound/Fraction Ec D Ef Kp Kp D Sa Sa D Ng 
DCM >2.5 0.15 >2.5 >2.5 1.25 >2.5 1.25 
EtOAc >2.5 0.078 >2.5 >2.5 0.078 >2.5 >2.5 
Hex >2.5 1.25 >2.5 >2.5 0.13 >2.5 >2.5 
70 % aqueous MeOH >2.5 0.3 >2.5 >2.5 0.1 >2.5 0.6 
EtOAc fraction 1 - 0.031 - - 0.061 - - 
EtOAc fraction 2 - >1 - - >1 - - 
EtOAc fraction 3 - >1 - - >1 - - 
EtOAc fraction 4 - >1 - - >1 - - 
EtOAc fraction 5 - >1 - - >1 - - 
EtOAc fraction 6 - >1 - - >1 - - 
EtOAc fraction 7 - >1 - - >1 - - 
EtOAc fraction 8 - >1 - - >1 - - 
Sub-fraction 5 >1 0.25 >1 >1 0.25 >1 >1 
Compound 1 >1 0.016 >1 >1 0.016 >1 >1 
Compound 2 >1 >1 >1 >1 0.025 >1 >1 
Neomycina (µg/ml)  >100 5.25 >100 >100 3.9 25 - 
Ciprofloxacina (µg/ml) - - - - - - 7 
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Both E. faecalis and S. aureus contribute extensively to the global health and economic burdens 
associated with drug-resistant bacterial strains. GOULD (2009) noted that some methicillin-
resistant S. aureus (MRSA) mutants acquired advanced resistance to all five major classes of 
antibiotics (cephalosporins, penicillin, carbapenems, quinolones and aminoglycosides) present 
at the time. Also, despite current treatment efforts, the morbidity and mortality rates associated 
with E. faecalis infections remain very high due to the prevalence of antibiotic resistance 
mutants (BILLINGTON et al., 2014). This is indeed a serious cause for alarm given that these 
two bacterial strains cause serious life-threating diseases such as bacteraemia, meningitis, toxic 
shock syndrome, septicaemia and several nosocomial infections (MACPHEE et al., 2013; 
RUBINSTEIN AND KEYNAN, 2013; GOMEZ et al., 2015; KHAN et al., 2015; POORABBAS et al., 
2015; AFZELIUS et al., 2016). Developing new classes of antibiotics would help alleviate the 
socio-economic challenges emanating from drug-resistance. The current findings, therefore, 
underscore the importance of ethnopharmacology in helping scientists discover new sources 
and classes of potent antimicrobial agents. 
 
It was interesting to note that antibacterial efficacy improved as the fractions were repeatedly 
and progressively purified. For instance, there was approximately a 5-fold reduction in the MIC 
value (inversely, an improvement in antibacterial efficacy) of compound 1  
(MIC = 0.016 mg/ml) as compared to the original EtOAc fraction (0.078 mg/ml) from which 
it was isolated (Figure 5.1 and Table 5.1). This observation suggested that the activities of these 
antibacterial compounds were probably antagonised by other chemical constituents within the 
initial crude extracts/fractions. Furthermore, since the weight of compound 1  
(0.7 mg) and compound 2 (1.2 mg) constituted approximately 0.01 % and 0.02 % (respectively) 
of that of the EtOAc fraction (7.87 g) from which they were isolated, these compounds were 
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perhaps over diluted during the early stages of the isolation procedure to reveal their actual 
antibacterial efficacy.  
 
5.3.1.2. NMR assignments 
Although the structure of compound 1 is still to be determined a high-field 1HNMR spectrum 
from the small quantity of material (0.7 mg) isolated and purified by silica gel column 
chromatography was acquired. The 500 MHz 1HNMR spectrum (Figure 5.2) of compound 1 
indicated an appreciably clean compound. Three sets of signal resonances were detected in the 
regions  6.7 to 7.3,  4.3 to 4.8 and  0.4 to 1.7 as depicted in Figures 5.2.1-5.2.3. The 
expanded spectrum resolved the signals clumped at  6.7 to 7.3 into two multiplets, the more 
deshielded of which was centred at  7.19 (2H, m, J=2.5, 3.0, 5.0 Hz) and the other at  7.12 
(2H, m, J=1.5, 7.0, 7.5 Hz). The chemical shifts, multiplicities and coupling constants for these 
signals are characteristic of the protons in an aromatic ring system. The signal at  6.76 which 
resolved to a double doublet also integrated to 2 protons with coupling constants of 6.0 and 
12.0 Hz, respectively, can be suggested to belong to a double bond system. The broad singlet 
at  4.57 (1H) is ascribable to an oxygen-related methine proton. Methyl proton signals which 
resolved to sharp singlets (each 3H) were detected upfield at  1.55, 1.28, 1.25 and 1.20, 
respectively. The remaining proton signals which integrated to 9 protons stretched from  0.4 
to 0.9 (m) were indicative of methylene and methine protons in the molecule. 
 
 
88 
 
 
Figure 5.2: 1HNMR spectrum (500 MHz) of compound 1 (isolated from the leaves of Searsia lancea) run in deuterated 
chloroform. 
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Figure 5.2.1: 1HNMR spectrum (500 MHz) expansion ( 6.7-7.3) of compound 1 (isolated from the leaves of Searsia lancea)  
run in deuterated chloroform.    
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Figure 5.2.2: 1HNMR spectrum (500 MHz) expansion ( 4.3-4.8) of compound 1 (isolated from the leaves of Searsia  
lancea) run in deuterated chloroform.    
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Figure 5.2.3: 1HNMR spectrum (500 MHz) expansion ( 0.4-1.7) of compound 1 (isolated from the leaves of Searsia  
lancea) run in deuterated chloroform.  
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Similar to compound 1 described above, compound 2 was isolated in a small quantity (1.2 mg) 
that restricted extensive analytical and spectroscopic analyses. However, the 1HNMR spectrum 
obtained at 400 MHz together with its TLC profile [DCM/Hexane (1:1)] confirmed that the 
compound was satisfactorily clean. Figure 5.3 depicts the high-field NMR spectrum of 
compound 2 run in deuterated chloroform as solvent. Three sets of signals were detected in the 
range  7.4 to 7.8 (low-field),  4.1 to 4.3 (mid-field) and  0.8 to 1.8 (high-field) as shown in 
Figures 5.3.1-5.3.3. The low-field signals were a symmetrical pair of multiplets resonant at  
7.69 (1H, m, J=3.0, 4.0, 7.0, Hz) and  7.51 (1H, m, J=3.0, 4.0, 7.0, Hz) which suggested them 
to be protons belonging to an aromatic system. The mid-field region of the spectrum was 
populated by a septet at  4.22 (2H, J=6.5, 7.5, 14.0 Hz). Such a spin system is diagnostic of a 
methine proton flanked by two methyl groups (responsible for the splitting pattern) as well as 
an oxygen-related functionality (responsible for the deshielding effect). The high-field area of 
the spectrum had signal resonances as follows: (i)  1.69 (1H, quintet, J=7.5, 7.5, 15.0 Hz), (ii) 
 1.56 (1H, s), (iii)  1.37 (9H, m), and (iv)  0.90 (6H, m). The resonance at  1.69 can be 
attributed to a methine proton flanked by two methylene groups, that at  0.90 indicated the 
presence of at least one methyl group given the sharp intensity of the peak, whilst the  1.37 
signal resonance is indicative of methylene and methine protons. 
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Figure 5.3: 1HNMR spectrum (400 MHz) of compound 2 (isolated from the leaves of Searsia lancea) run in deuterated  
chloroform.   
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Figure 5.3.1: 1HNMR spectrum (400 MHz) expansion ( 7.4-7.8) of compound 2 (isolated from the leaves of Searsia  
lancea) run in deuterated chloroform.     
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Figure 5.3.2: 1HNMR spectrum (400 MHz) expansion ( 4.1-4.3) of compound 2 (isolated from the leaves of Searsia  
lancea) run in deuterated chloroform.    
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Figure 5.3.3: 1HNMR spectrum (400 MHz) expansion ( 0.8-1.8) of compound 2 (isolated from the leaves of  
Searsia lancea) run in deuterated chloroform.
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5.3.1.3. GC-MS analysis of a bioactive Searsia lancea methanol leaf extract 
sub-fraction. 
A sub-fraction [sub-fraction 5 (SFR-5)] obtained from the EtOAc fraction 1 (Figure 5.1) 
yielded an MIC value of 0.25 mg/ml against both E. faecalis and S. aureus (Table 5.1). 
However, only 0.5 mg of SFR-5 were obtained making it difficult to purify the sub-fraction 
further using preparative TLC. GC-MS analysis (Table 5.2 and Figure 5.4) revealed that the 
major components of this sub-fraction were 1-tetracosanol (43.98%) and 1-nonadecanol 
(37.5%). In addition, the sub-fraction also consisted of eicosane (7.67%),  
1,7-di-iso-propylnaphthalene (4.23%), 1-pentadecanol (3.04%), 2,6-di-iso-propylnaphthalene 
(1.96%) and 1,3-iso-propylnaphthalene (1.62%). Although these seven phytocompounds are 
well-known, the current study revealed their presence in S. lancea for the first time. Based on 
the currently available literature, this is also the first report on the presence of  
1,3-iso-propylnaphthalene, 1-1,7-di-iso-propylnaphthalene, 2,6-di-iso-propylnaphthalene,  
1-pentadecanol, and 1-tetracosanol in Searsia (Rhus) species. Eicosane was previously 
detected in Rhus vernicifera (JAVIDNIA et al., 2008) and Rhus succedanea (HUIPING, 1987), 
while 1-nonadecanol was found in Rhus coriaria (BAHAR AND ALTUG, 2009). 
 
GEHRKE et al. (2013) demonstrated that 1-nonadecanol (Figure 5.5) has potent inhibitory 
activities against some Gram-positive (B. subtilis, S. aureus, Staphylococcus epidermis, 
Streptococcus pyogenes, Staphylococcus saprophyticus) and Gram-negative (E. coli, Shigella 
sonnei) bacterial strains, with MIC values ranging between 0.05-0.2mg/ml. The authors also 
reported that the same compound possesses antifungal properties. Work by RUKACHAISIRIKUL 
et al. (2004) also revealed that 1-nonadecanol has potent anti-tuberculosis activities 
 (MIC = 0.025mg/ml). As demonstrated by 1-nonadecanol, 1-tetracosanol (Figure 5.5) was also 
shown to have broad-spectrum antibacterial activities (MAHMOOD et al., 2014). Some fungi, 
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especially actinomycetes, have also been reported to produce 1-tetracosanol  
(VENUGOPAL et al., 2014), probably as part of their natural defence mechanism.  
 
Another putative antibacterial compound detected in SFR-5 was eicosane (Figure 5.5), which 
together with 1-nonadecanol and pentadecanol were previously detected in plant extracts with 
antimicrobial (SUKATAR et al., 2006; KARABAY‐YAVASOGLU et al., 2007; 
MOHAMMADZADEH et al., 2007; AL‐REZA et al., 2009), analgesic, anti-inflammatory and 
antipyretic (PANTHARI et al., 2012; AL-SNAFI, 2016; SUN et al., 2017) properties.  
1-Nonadecanol and eicosane are both long chain fatty acids whose antibacterial mechanisms 
are believed to be associated with their strong radical oxygen scavenging properties 
(YASA et al., 2009).  
 
1-Nonadecanol and 1-tetracosanol are known antibacterial compounds which could have 
contributed to the antibacterial properties of SFR-5 (Table 5.1). There is, however, a possibility 
that other phytochemical constituents of SFR-5 such as eicosane worked individually or 
synergistically to effect the antibacterial activities observed in the present study, an area that 
warrants further investigation. The antibacterial compounds in this medicinal plant should 
therefore be isolated and unequivocally identified using spectroscopic and X-ray data analysis. 
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Table 5.2: GC-MS data of phytocompounds putatively identified in a bioactive Searsia lancea leaf ethyl acetate sub-fraction.  
 
 
 
 
 
 
 
 
 
 
 
Chemical name Similarity % Area % Retention time Molecular formulae Molecular weight 
1-Tetracosanol 96 43.98 19.46 C24H50O 354 
1-Nonadecanol 95 37.5 15.91 C19H40O 284 
Eicosane 95 7.67 15.99 C20H42 282 
1,7- Di-iso-propylnaphthalene 93 4.23 15.16 C16H20 212 
1-Pentadecanol 92 3.04 13.74 C15H32O 228 
2,6- Di-iso-propylnaphthalene 87 1.96 15.22 C16H20 212 
1,3-Di-iso-propylnaphthalene 91 1.62 14.66 C16H20 212 
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Figure 5.4: GC-MS chromatogram of a Searsia lancea leaf ethyl acetate sub-fraction. a = 1-Pentadecanol, 
b = 1,3-Di-iso-propylnaphthale, c = 1,7-Di-iso-propylnaphthale, d = 1-Nonadecanol, e = Eicosane, f = Eicosane,  
g = Eicosane, h = 1-Tetracosane. 
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Figure 5.5: Mass spectra and chemical structures of antibacterial compounds (eicosane and 1-nonadecanol) putatively identified by 
GC-MS in a Searsia lancea leaf ethyl acetate sub-fraction.  
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Figure 5.5: Continued (Mass spectra and chemical structures of 1-pentadecanol and 1-tetracosanol). 
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5.3.2. Identification of putative antibacterial compounds in Protea caffra 
P. caffra twigs exhibited broad-spectrum antibacterial activities (Table 3.1-3.2, Chapter 3) 
and this novel finding stimulated interest in determining their phytochemical profiles. Acetone, 
cold ethyl acetate and hot ethyl acetate were used to fractionate the phytocompounds in a 
methanolic extract of P. caffra twigs. The MIC values of the resultant four sub-fractions are 
presented in Table 5.3.  
 
All sub-fractions, except the acetone fraction, demonstrated noteworthy antibacterial activities 
(MIC < 1mg/ml) against some of the test bacterial strains. The best antibacterial property was 
exhibited by the cold ethyl acetate fraction which was active against both Gram-negative  
(E. coli, K. pneumoniae) and Gram-positive (E. faecalis, S. aureus) bacterial strains, with MIC 
values ranging between 0.078 and 0.6 mg/ml. However, the methanol sub-fraction was active 
against only one test bacterial strain, S. aureus (MIC = 0.6). None of the fractions were active 
against N. gonorrhoeae and the three drug-resistant bacterial strains evaluated. 
 
According to GC-MS, the P. caffra twig MeOH extract consisted of 15 compounds (Table 5.4). 
The GC-MS chromatograms of the sub-fractions evaluated are presented in  
Figures 5.6-5.9. No peaks were obtained from the methanol sub-fraction (Figure 5.9) 
suggesting that perhaps the temperatures used during GC-MS analysis could have been too low 
for the analyte to volatilize.   
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Table 5.3: Minimum inhibitory concentration (MIC, mg/ml) values of fractions obtained from 
a methanol extract of Protea caffra twigs. 
a = positive control, Ec D = Multidrug-resistant Escherichia coli, Ef = Enterococcus faecalis, 
Kp = Klebsiella pneumoniae, Kp D = Multidrug-resistant Klebsiella pneumoniae, 
Sa = Staphylococcus aureus, Sa D = Penicillin resistant Staphylococcus aureus, 
Ng = Neisseria gonorrhoeae, MeOH = Methanol, - = Not tested. 
*Values in bold are considered noteworthy. 
  
 MIC (mg/ml) 
Fraction Ec Ec D Ef Kp Kp D Sa Sa D Ng 
Acetone >2.5 >2.5 >2.5 >2.5 >2.5 1.5 >2.5 >2.5 
Cold ethyl acetate 0.6 >2.5 0.078 0.3 >2.5 0.15 >2.5 >2.5 
Hot ethyl acetate >2.5 >2.5 0.3 >2.5 >2.5 0.6 >2.5 >2.5 
MeOH >2.5 >2.5 >2.5 > 2.5 >2.5 0.6 >2.5 >2.5 
Neomycina (µg/ml)  >100 >100 5.25 >100 >100 3.9 25 - 
Ciprofloxacina (µg/ml) - - - - - - - 7 
 
 
105 
 
The major components of the cold ethyl acetate sub-fraction were polygalitol (34.76%), phenol, 
4-(1,1,3,3-tetramethylbutyl) (9.8%), Spiro-1-(cyclohex-2-ene)-2’-(5’-oxabicyclol) (8.2%),  
1-adamantanecarboxylic acid (8.07%) and carbamic acid (7.03%), which together accounted 
for approximately 60% of the total compounds found within that sub-fraction (Table 5.4). Some 
phytochemical constituents within this sub-fraction namely 1-adamantanecarboxylic acid,  
1-heptacosanol and 1-nonadecanol (Figures 5.5 and 10) are known biologically active 
phytocompounds which most likely contributed to the antibacterial property of P. caffra twigs 
(Table 3.1-3.2).  
 
1-Adamantyl heterocycle is often incorporated into anti-infectious molecules to improve their 
efficacy (HASSAN et al., 2010). Several potent antimicrobial and antiviral agents such as 
Rimantadine (MANCHAND et al., 1990), Oxadiazole (EL-EMAM et al., 2004), Isoxazole 
(MAKAROVA et al., 2002) and Thiadiazole (KRITSANIDA et al., 2002) are all 1-adamantanyl 
derivatives. 1-Heptacosanol, another compound detected in the cold ethyl acetate fraction, is a 
fatty alcohol present in plants (KOAY et al., 2013), marine algae (MURUGAN AND IYER, 2014) 
and cuttlefish, Sepiella inermis (RAVICHANDIRAN et al., 2013). This compound has potent 
antibacterial (SHARMA AND MENGHANI, 2017) and antifungal (SUDIRGA AND GINANTRA, 
2017) properties. It also has several potential therapeutic applications given that it was detected 
in medicinal plant extracts with antioxidant (MURUGAN AND IYER, 2014;  
AL-ABD et al., 2015), nematocidal (SULTANA et al., 2010) and antidiabetic 
(UNNIKRISHNAN et al., 2014) properties. Unlike 1-nonadecanol which is a known antibacterial 
phyto-compound (YASA et al., 2009), polygalitol has not yet been shown to have antibacterial 
properties, but, has been detected in plant extracts with potent antibacterial activities 
(ALAGAMMAL et al., 2012), suggesting the compound could have some antimicrobial 
properties. 
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Table 5.4: GC-MS data of phytocompounds putatively identified in different sub-fractions of methanolic extracts of Protea caffra twigs.  
 
 
 
 
 
 
 
 
 
 
 
Sub-fraction Chemical name Similarity 
% 
Area 
% 
Retention 
time 
Molecular 
formulae 
Molecular 
weight 
Cold ethyl 
acetate 
Polygalitol 95 34.76 13.35 C6H12O5 164 
 Phenol, 4-(1,1,3,3-tetramethylbutyl)- 89 9.8 15.38 C14H22O 206 
 Spiro-1-(cyclohex-2-ene)-2’-(5’-oxabicyclol) 77 8.2 14.94 C14H22O 206 
 1-Adamantanecarboxylic acid, 2-propenyl 89 8.07 15.03 C14H20O2 220 
 Carbamic acid, N-[1,1-bis(trifluoromethyl)ethyl 90 7.03 14.85 C19H25F6NO2 413 
 Phenol, 2-methyl-4-(1,1,3,3-tetramethylbutyl)- 80 6.23 15.27 C15H24O 220 
 Hexestrol, O-acetyl- 88 3.57 15.16 C20H24O3 312 
 1-Heptacosanol 94 2.86 19.41 C27H560 396 
 1,2-Bis(p-acetoxyphenyl)ethanedione 77 2.1 14.74 C18H1406 326 
 1,3-Benzenediol, 4-propyl- 83 1.83 13.73 C9H1202 152 
 Phthalic acid, butyl tridecyl ester  75 1.74 18.53 C22H28O4 356 
 1-Nonadecanol 93 1.60 15.89 C19H40O 284 
 Phenol 2,4-bis(1,1-dimethylethyl) 94 1.16 12.84 C14H22O 206 
Hot ethyl 
acetate 
1-Heptacosanol 90 70.57 14.16 C27H560 396 
 1,3,5-Benzenetriol 95 15.42 13.55 C6H603 126 
 Polygalitol 72 7.31 12.99 C6H12O5 164 
 1,3-Benzenediol, 4-propyl- 70 3.93 13.73 C9H12O2 152 
 ß-Glucopyranose, 1,6-anhydro-  70 2.78 11.60 C6H10O5 162 
 1-Nonadecanol 93 1.6 15.89 C19H40O 284 
Acetone Oxalyl acid 93 51.12 3.23 C2CI2O2 126 
 Polygalitol 95 48.88 13.22 C6H12O5 164 
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Figure 5.6: GC-MS chromatogram of a cold ethyl acetate sub-fraction obtained from  
methanolic extracts of Protea caffra twigs. a = Phenol 2,4-bis(1,1-dimethylethyl); 
b = Polygalitol; c = 1,3-Benzenediol, 4-propyl-; d = 1,2-Bis(p-acetoxyphenyl) ethanedione;    
e = 1-Adamantanecarboxylic acid, 2-propenyl; f = Phenol, 2-methyl-4-(1,1,3,3-
tetramethylbutyl)-; g = Phenol, 4-(1,1,3,3-tetramethylbutyl)-; h = Phenol, 2-methyl-4-(1,1,3,3-
tetramethylbutyl)-; i = 1-Nonadecanol; j = Phthalic acid, butyl tridecyl ester;  
K = 1-Heptacosanol. 
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Figure 5.7. GC-MS chromatogram of a hot ethyl acetate sub-fraction obtained from 
methanol extracts of Protea caffra twigs. a = ß-Glucopyranose, 1,6-anhydro-,  
1,6-anhydro-; b = Polygalitol; c = 1,3,5-Benzenediol, 4-propyl-; d = 1,3-Benzenediol,          
4-propyl-; e = 1-Heptacosanol. 
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Figure 5.8: GC-MS chromatogram of an acetone sub-fraction obtained from methanolic extracts of 
Protea caffra twigs. a = Oxalyl acid; b = Polygalitol. 
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Figure 5.9: GC-MS chromatogram of a methanol sub-fraction obtained from methanol 
extracts of Protea caffra twigs. 
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Figure 5.10: Mass spectra and chemical structures of antibacterial compounds (1-adamantanecarboxylic acid and 1-heptacosanol) 
putatively identified by GC-MS in methanolic Protea caffra extract sub-fractions. 
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Figure 5.10: Continued (levoglucosan, polygalitol).   
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The hot ethyl acetate fraction consisted of 1-heptacosanol (70.57%), 1,3,5-benzenetriol 
(15.42), and polygalitol (7.31%) as its major components (Table 5.4). As already alluded to,  
1-heptacosanol possesses potent antibacterial properties and since it was the major 
phytochemical constituent in this fraction, it was probably the one that inhibited the growth of 
both E. faecalis and S. aureus in the present investigation (Table 5.3). Polygalitol and other 
phytocompounds detected in this sub-fraction could also have contributed to the observed 
antibacterial activities. It was of great interest to note that P. caffra produces levoglucosan 
(Figure 5.10), an important source of C1-C10 and C1-C13 carbon skeletons used to produce 
the antibiotics erythromycin A and B (KOCHETKOV et al., 1989; SVIRIDOV et al., 1990).  
 
As shown in Table 5.4, only two compounds were identified in the acetone sub-fraction 
namely, oxalyl chloride (51.12%) and polygalitol (48.88%). Oxalyl chloride is a synthetic 
compound used in the oxidative processes involved in manufacturing antibiotics, pesticides, 
herbicides and other organic products (ABUBAKER AND WANDRUSZKA, 1991; 
MAO et al., 2004). There are no indications in the current literature suggesting that this 
compound is produced by plants and that it is biologically active. Oxalyl chloride was therefore 
probably incorporated into P. caffra tissues from an external source. Further investigation 
would reveal which of the two compounds present in this fraction was responsible for the weak 
antibacterial activity observed against S. aureus (MIC ≥ 1.25 mg/ml).  
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5.4. Conclusions 
The unprecedented evolution and global spread of drug-resistant bacterial strains pose a serious 
threat to global public health. New effective antibiotics are therefore urgently needed to prevent 
an era of untreatable bacterial infections. Due to their intricate chemical diversity, plants are 
potential rich sources of therapeutic drugs. The two compounds (compound 1 and  
compound 2) isolated from the leaves of S. lancea in the present study exhibited promising 
inhibitory activities against E. faecalis and S. aureus (MIC range: 0.016-0.25 mg/ml). These 
findings substantiate the traditional use of S. lancea to manage fevers and diarrhoea. However, 
both compounds were isolated in low quantities (<1.5 mg) and hence could not as yet be 
unequivocally identified through 1-D and 2-D NMR spectroscopic data analysis. The study, 
however, provides important leads for future investigations which could be strengthened by 
the analysis of larger plant mass. If the isolated antibacterial compounds are novel, their 
structures could be used as models upon which new antibacterial agents could be designed. 
Due to its efficacy (0.016 mg/ml), compound 1 could be used directly as an active ingredient 
in some anti-infection pharmaceuticals. It is, however, imperative that the mode of action, 
safety, pharmacodynamic and pharmacokinetic potentials of both compounds be fully 
investigated to ascertain their clinical potentials. 
 
GC-MS analysis revealed the presence of two antibacterial compounds (1-nonadecanol and  
1-tetracosanol) in S. lancea leaves, which further justified the traditional use of this plant to 
treat bacterial infections. However, further studies are warranted to confirm the identity of these 
compounds using IR, NMR and X-ray data analysis. In addition, the pharmacological and 
toxicological properties of these compounds need to be thoroughly investigated.  
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Based on GC-MS, the P. caffra twigs methanol extract evaluated, consisted of 15 volatile 
compounds. Two of the detected compounds, 1-adamantanecarboxylic acid and levoglucosan, 
are often incorporated into antimicrobial moieties either as carbon skeletons or to improve the 
efficacy of the parent drug. The study also revealed that P. caffra is a potential source of two 
known antibacterial compounds namely 1-heptacosanol and 1-nonadecanol, and another 
compound, polygalitol, believed to possess antibacterial properties. Further studies are, 
however, warranted to determine the specific bioactive molecules responsible for the 
antibacterial properties of P. caffra twigs observed in the present investigation. 
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CHAPTER 6: GENERAL CONCLUSIONS 
 
In light of the current widespread evolution of drug-resistant microbial strains, recent  estimates 
predicts that by the year 2050, the leading cause of death globally would be infections caused 
by drug-resistant microbial mutants (O’NEILL, 2014). The current state of affairs dictates an 
urgent need to develop new effective antibiotics, as well as to restore the efficacy of ineffective 
antibiotics. Natural products and their derivatives have attracted so much attention as potential 
sources of drug leads that could be effective in combating drug-resistance microbial strains. 
The current study was aimed mainly at identifying the principal antibacterial compounds in 
South African medicinal plants with potent and extended-spectrum antibacterial properties.  
 
The seven medicinal plants (Bolusanthus speciosus, Cucumis myriocarpus, Ekebergia 
capensis, Prunus africana, Protea caffra, Searsia lancea and Solanum panduriforme) 
evaluated were selected based on their ethnomedicinal uses, pharmacological potentials and 
plant material availability. Aqueous and organic solvent extracts from these plants were 
subjected to antibacterial susceptibility testing, mutagenicity evaluations and phytochemical 
profiling to identify plants with the best pharmacological and phytochemical properties to 
consider for further phytochemical analysis. Subsequently, bioactivity-guided isolation 
techniques were used to isolate antibacterial compounds from the leaves of S. lancea. 
Spectroscopic data analysis revealed the chemical properties of the isolated compounds. The 
phytochemical constituents of an active S. lancea leaf ethyl acetate sub-fraction and that of a 
methanolic extract of P. caffra twigs were putatively identified using GC-MS.  
 
The study revealed for the first time the antigonococcal properties of P. africana and  
S. lancea leaves. If traditional healers/herbalists could include these two plants in managing 
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gonorrhoea, that would not only help delay the evolution of antimicrobial-resistant gonococcal 
strains, but will also help conserve our biodiversity by preventing the overharvesting of the few 
medicinal plants currently being used to treat this venereal disease. The antibacterial 
compounds in these medicinal plants should, however, be identified and assessed for their 
potential use in mono- and combination therapies. This might in the long run help alleviate the 
global burden of gonorrhoea, which in more recent years has been linked with increased Human 
immuno-deficient virus (HIV) infection rates. 
 
The current study also reaffirmed that there is a high-risk of obtaining pseudo-negative results 
when plant extracts are screened for antibacterial activities using the disk-diffusion technique. 
The microdilution bioassay was found to be much more sensitive in screening test plant extracts 
for antibacterial properties than the disk-diffusion assay.  
 
The DCM bark extract from B. speciosus yielded the overall best antibacterial activity  
(MIC = 0.039 mg/ml against penicillin-resistant S. aureus) and demonstrated broad-spectrum 
antibacterial activities. P. caffra seeds (DCM extract) and twigs (MeOH extract), as well as  
S. lancea leaves (MeOH extract) also demonstrated broad-spectrum antibacterial activities. 
Interestingly, B. speciosus, P. africana and S. lancea exhibited promising activities against 
Gram-negative, MDR bacterial strains (E. coli and K. pneumoniae). By inference, clinically 
relevant broad-spectrum and potent antibacterial compounds effective against both  
drug-sensitive and multi-drug resistant (MDR) bacterial strains could potentially be obtained 
from medicinal plants. 
 
There are growing concerns that the continued irrational use of antibiotics might cause several 
MDR bacterial strains to acquire advanced resistance and ultimately evolve into mutants 
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resistant to all known classes of antibiotics, a phenomenon known as extensive drug-resistance. 
To curb the development of advanced drug-resistance, concerted efforts should be made to 
discover antimicrobial agents effective against MDR bacterial strains from medicinal plants 
such as B. speciosus, P. africana and S. lancea. Given that these three plants belong to different 
taxonomic groups, chances are that their bioactive compounds are structurally diverse and each 
of them has a unique antibacterial mode of action. Future studies should therefore not only 
focus on identifying the antibacterial compounds in each of these medicinal plants, but 
consideration should also be given to elucidating their antibacterial mechanisms. Given that 
plants have an unlimited potential to produce chemically diverse secondary metabolites 
(GURIB-FAKIM, 2006), there are reasonable prospects of discovering novel classes of 
antibacterial agents from these natural resources.  
 
Apart from discovering new antibacterial agents and novel classes of antibiotics from plants, 
the problem of antimicrobial-resistance could also be successfully tackled by discovering 
compounds that can reverse the effects of drug-resistance. In a bid to find these compounds, a 
preliminary study was conducted to assess the antibacterial synergistic interactions between 
different plant extracts, as well as between the plant extracts and antibiotics against  
MDR E. coli and MDR K. pneumoniae. A comparison of the checkerboard and time-kill results 
indicated that the former overestimated the degree to which chloramphenicol (antibiotic) 
synergistically interacted with three different plant extracts (B. speciosus MeOH bark extract, 
P. africana DCM and MeOH leaf extracts) against MDR E. coli. It is therefore recommended 
that all synergistic interactions detected within combinations of antibiotics and plant extracts 
by the checkerboard bioassay be re-affirmed using the more sensitive time-kill bioassays, as is 
customary in most clinical trials. 
 
 
 
119 
 
The chemo-diversity present in the plant kingdom provides exciting prospects of discovering 
antibiotic-resistance modifying phytocompounds and as such, searching for these compounds 
should become one of the top research priorities, especially in many African countries with a 
rich biodiversity. Scientific evaluations of synergistic combinations utilised in traditional 
medicine could open new avenues for novel pharmaceutical drug discovery. Using these 
natural products in combination therapies to potentiate the efficacy of some currently available 
antibiotics will undoubtedly prolong the era of successful antibiotic therapy. Additionally, this 
approach seems more financially appealing compared to developing new synthetic drugs that 
will have to undergo lengthy clinical trials prior to approval. 
 
The test plant organs contained varying concentrations of total phenolics, condensed tannins, 
flavonoids, hydroxybenzoic and hydroxycinnamic acids. The extended-spectrum activities 
demonstrated by some extracts from P. africana leaves, P. caffra twigs and S. lancea leaves 
could be attributed to higher levels of phenolic compounds within these plant organs. However, 
even though the bark of B. speciosus demonstrated the best antibacterial activity in the current 
study, they contained very low quantities of almost all phenolic compounds assessed. It was 
interesting also to note that some plant organs such as the leaf, bark and flower of P. caffra and 
the leaf of E. capensis contained relatively higher levels of different phenolic compounds but 
did not yield noteworthy antibacterial activities (MIC > 1 mg/ml). Empirically, both the 
quantity and quality of phenolic compounds present in medicinal plant extracts seemed equally 
important in determining antibacterial efficacy and spectrum. Even though these two 
parameters are crucial, the possibility remains that different phenolic compounds synergised 
each other to effect the observed antibacterial activities, an area that future studies could 
possibly explore. It is also recommended that plant organs that did not demonstrate good 
antibacterial activities (MIC > 1 mg/ml) but contained higher levels of phenolic compounds 
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should be screened for other relevant pharmacological activities such as antioxidant, antiviral, 
antifungal, anti-inflammatory, antimutagenic and anticancer properties. 
 
Based on the Ames test, all medicinal plant extracts that demonstrated noteworthy antibacterial 
activities in the present study were non-mutagenic against two S. typhimurium tester strains, 
TA98 and TA102 (without S9 metabolic activation). While this is an encouraging finding, 
further in vivo and in vitro toxicological studies are necessary before these medicinal plants are 
regarded entirely safe to use in both conventional and folk medicine.  
 
The two compounds isolated from the leaves of S. lancea exhibited noteworthy inhibitory 
effects on E. faecalis and S. aureus (MIC: 0.016-0.25 mg/ml). However, since both compounds 
were obtained in low quantities (< 1.5 mg) their identity was not confirmed and it was also not 
possible to screen them for other pharmacological activities. Apart from structural elucidation 
and identifying them, it is imperative that their antibacterial mechanisms, pharmacodynamic 
and pharmacokinetic properties be determined to ascertain their clinical relevance.  
 
GC-MS revealed the presence of 1-tetracosanol, 1-nonadecanol, eicosane, 1,7-di-iso-
propylnaphthalene 1-pentadecanol, 2,6-di-iso-propylnaphthalene 1,3-iso-propylnaphthalene in 
S. lancea leaves. 1-Nonadecanol and 1-tetracosanol are known antibacterial compounds, which 
together with eicosane have been detected in several essential oils with antibacterial properties. 
The study therefore provides further evidence suggesting that S. lancea is a potential source of 
essential oils with therapeutic advantages. However, the antibacterial compounds in this 
medicinal plant still need to be unequivocally identified through spectroscopic data analysis. 
Furthermore, the toxic potentials of each of these compounds need to be thoroughly assessed. 
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GC-MS analysis also revealed the presence of 1-adamantanecarboxylic acid, 1-heptacosanol, 
levoglucosan, 1-nonadecanol and polygalitol in P. caffra. This is the first report on the presence 
of these pharmacologically important phytocompounds in P. caffra, an ornamental plant rarely 
used in folk medicine. Based on these findings, it is recommended that the other members of 
Protea species (> 300) be explored as potential sources of anti-infection and other therapeutic 
molecules.   
 
Overall, the findings from this study underscore the important role that medicinal plants could 
play, if fully exploited, in addressing the triple-challenge of drug-resistance, looming 
pharmaceutical drug shortages and increasing human mortality rates. 
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